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ABSTRACT OF THE DISSERTATION 
Multi-omic Understanding of the Evolution of Xenobiotic Tolerance in Bacterial Isolates and 
Communities 
by 
Tayte P. Campbell 
Doctor of Philosophy in Biology and Biomedical Sciences 
Plant and Microbial Biosciences 
Washington University in St. Louis, 2019 
Professor Gautam Dantas, Chair 
Xenobiotic compounds are any chemicals that are released into an environment by human 
action and that occur at concentrations higher than found naturally. Xenobiotics, including 
aromatic compounds and antibiotics, are recalcitrant to degradation because they are often toxic 
or mutagenic. Despite this toxicity, bacteria account for a large portion of xenobiotic degradation 
in the environment. Bacteria are able to adapt to these foreign chemicals, gaining increased levels 
of tolerance and increased rates of xenobiotic degradation. On the strain level, increased tolerance 
can be caused by mutations in individual cells or through the acquisition of genes from other cells. 
At the community level, xenobiotics select for naturally resistant bacterial often resulting in an 
increase in genes involved with xenobiotic tolerance. The goal of my thesis was to (1) understand 
how bacterial strains evolve increased tolerance to toxic aromatics xenobiotics through adapted 
evolution and (2) how microbial communities in mammalian guts are altered due to xenobiotic 
selection pressure.  
To determine the microbial adaptations that occur in bacterial strains exposed to 
xenobiotics, I studied the changes that occurred in the genome and transcriptome of Rhodococcus 
x 
 
opacus PD630 when grown over several generations on increasing concentrations of toxic 
aromatic compounds. Chemical pretreatment of lignocellulose as a first step in biofuel production 
results in the creation of monomeric sugars and toxic xenobiotic compounds. Bacterial conversion 
of the resulting moiety to biofuel precursors is one of the most cost-effective methods of biofuel 
production. However, the toxic aromatic compounds created from lignocellulose pretreatment 
inhibit bacterial growth and reduce overall productivity. R. opacus is a bacterial strain that 
naturally has a high tolerance to aromatic compounds and optimization of this bacteria can improve 
process efficiency. By analyzing 35 R. opacus strains adapted on 6 different compounds or 
compound mixtures, I show that adapted strains demonstrated up to 1900% improvement in final 
cell densities. I found no mutations in xenobiotic degradations genes for the adapted strains, but I 
found several mutations in genes that are involved with oxidation-reduction reactions that may 
assist in degradation. These results demonstrate that bacterial strains can gain increased xenobiotic 
tolerance by fine-tuning metabolic pathways indirectly related to xenobiotic degradation.   
To determine the effects of xenobiotic selection on microbial communities, I studied the 
gut microbiome of humans, captive chimpanzees, and captive gorillas that have received antibiotic 
treatment compared to the microbiome of wild chimpanzees and gorillas that have never received 
antibiotic treatment. I found that antibiotic treatment was correlated with higher richness and 
abundance of antibiotic resistance genes. In addition, the microbiome and resistome in captive 
apes were more similar to that of humans than to the wild apes, despite differences in host species 
and large geographic distances between the human and captive apes. Together, these results 
suggest that host lifestyle, including diet and antibiotic treatment, is more influential in 
microbiome composition than host species and geographic proximity.  I also identified a number 









 Xenobiotics have been produced in enormous quantities over the past century as a result of 
industrial activity [1]. In a broad sense, xenobiotics are any compounds that are foreign to the 
natural environment or found at much higher concentrations than usual [2]. They may either be 
artificially synthesized (e.g. chlorinated biphenyls, alkylbenzyl sulphonates, and halocarbons), 
natural products used at high concentrations (e.g. most antibiotics), or created by incomplete 
combustion of organic materials (e.g. phenolics and polycyclic aromatic hydrocarbons (PAHs)) 
[3-6]. Xenobiotic compounds are often toxic and recalcitrant to biodegradation, leading to 
contamination of the environment and bioaccumulation in living organisms [7]. Bacterial 
degradation of xenobiotics can be harnessed to either degrade unwanted pollutants to harmless 
byproducts through bioremediation, or to convert abundant xenobiotics to value added chemicals 
[8, 9]. In the case of antibiotics, targeted xenobiotic toxicity is utilized to kill pathogenic microbes 
in host organisms without harming the host [10]. However, microorganisms are becoming more 
resistant to antibiotics and increasingly able to metabolize antibiotic compounds to harmless 
byproducts [11, 12]. Understanding the microbial processes necessary for xenobiotic tolerance and 




industrial production, while also providing key insight to combat the spread of antibiotic 
resistance. 
1.2 Mechanisms of Xenobiotic Toxicity 
 
Many aromatic xenobiotics cause toxicity through the formation of quinones in the cell 
[13]. Quinones, fully conjugated cyclic compounds, are toxic due to the creation of free radicals 
that react with cell components [13, 14]. For example, free radicals damage cells by causing DNA 
mutations and by oxidizing lipids, amino acids, and carbohydrates [15, 16]. Quinones are 
particularly toxic because when they interact with cellular enzymes it leads to a phenomenon 
termed futile redox cycling. Specifically, futile redox cycling occurs when a cytochrome-P450 
reductase uses NADPH to reduce a quinone to semiquinone by adding one electron [17]. The 
resulting semiquinone rapidly reacts to produce a superoxide anion by passing the radical electron 
onto an oxygen molecule resulting in the formation of the original quinone, restarting the cycle 
[13]. The generated superoxide anion can then damage cell components with its highly reactive 
electron radical. Futile cycling thus leads to a rapid increase in harmful radical species within the 
cell while also depleting NADPH reservoirs within the cell [18]. Xenobiotics that cause toxicity 
through this mechanism are typically toxic to both prokaryotic and eukaryotic cells due to the non-
specific nature of free radical reactions [19].  
In contrast, antibiotic compounds are targeted to specific cell types and typically bind to 
targeted proteins or lipids [20]. This specific activity allows for their use to clear bacterial 
infections in humans and animals without causing harm to host cells and tissues [10, 21, 22]. 
Antibiotics target cellular components that are conserved across the bacterial domain of life and 
that are either absent or sufficiently different in host cells [23]. Current antibiotics only target a 




the cell wall synthesis pathway, the folate synthesis pathway, and proteins involved in DNA 
replication and maintenance [24]. Antibiotics bind to specific proteins and lipids resulting in 
inhibition of the protein activity when bound to the former or, when bound to the latter, disruption 
of the cell membrane. 
1.3 Xenobiotic Tolerance 
 
Bacterial tolerance to xenobiotic compounds in individual isolates is typically achieved 
through one of four common mechanisms: 1) xenobiotic degradation or modification, 2)  alteration 
or protection of the xenobiotic target, 3) active efflux of the xenobiotic, or 4) reduced permeability 
of the xenobiotic into the cell [10]. Since these resistance mechanisms cause resistance in different 
ways, the presence of more than one in a cell can result in higher levels of resistance [25]. For 
example, if a bacterial strain encodes both a xenobiotic degradation enzyme and has reduced 
permeability, then fewer xenobiotic compounds enter the cell and those that do are degraded [25]. 
When one mechanism becomes oversaturated, the other mechanism can compensate and keep 
xenobiotic concentrations low within the cell. In fact, multiple resistance mechanisms may be 
necessary for tolerance if both mechanisms have low specificity to the xenobiotic [25].  
 Bacterial enzymes have evolved over millennia to metabolize substrates that are commonly 
found in their natural environment [26]. Since xenobiotic compounds contain uncommon chemical 
structures or properties, bacteria often don’t intrinsically have enzymes that are capable of their 
degradation [27]. However, upon exposure to these unnatural compounds, bacteria are able to 
adapt relatively quickly and increase their levels of tolerance and degradation [28]. In fact, 
communities pre-exposed to specific xenobiotics or structurally similar compounds are able to 
increase their degradation rates up to 1,000-fold higher than unexposed populations [29]. Bacteria 




termed horizontal gene transfer or through acquired mutations that alter enzymatic specificities or 
create novel metabolic activities [2, 26]. 
In complex microbial communities, xenobiotic exposure selects for bacterial species that 
are able to tolerate the xenobiotic [26, 30]. One typical result of this selection pressure is reduced 
richness and diversity in bacterial communities as non-tolerant strains are often eliminated [31]. 
Another complication is that of these tolerance mechanisms, only microbial degradation reduces 
the amount of xenobiotic in the environment. As a result, degradation benefits bacteria with other 
resistance mechanisms and even bacteria that would otherwise be susceptible to the xenobiotic. 
These bacteria are termed cheaters since they benefit from the activity of other organisms [32]. 
This can lead to interesting community dynamics when the fitness cost of maintaining resistance 
genes is higher than the fitness cost of antibiotic susceptibility [33]. Paradoxically, the end result 
of this is selection against the individual strains that are performing xenobiotic degradation. Due 
to this wide array of community responses, it’s necessary to analyze the taxonomic changes along 
with the xenobiotic tolerance mechanisms in the community to begin to tease apart the community 
dynamics associated with xenobiotic selection pressure. DNA sequencing of microbial 
communities allows for both the identification of bacterial taxa and individual genes [34-36]. 
However, in complex microbial communities it can be difficult to associate specific genes with 
their host species, especially with the short DNA sequencing reads that are common today. With 
these limitations, correlational findings can be inferred statistically but may need longer 
sequencing lengths and co-culturing of simplified communities to further elucidate these 
dynamics. 





Even though biological process may occur at very slow rates, microbial conversion of 
xenobiotics provides a cost effective solution for bioremediation or industrial conversion processes 
[37, 38]. For example, lignocellulosic biomass, the most abundant biological compound on the 
planet, is often targeted for biological conversion to biofuels [39]. Lignocellulose is comprised of 
three main components: cellulose, hemicellulose, and lignin. Cellulose, and to a lesser extent 
hemicellulose, are easily depolymerized through enzymatic degradation into their component 
sugar molecules [40]. Lignin, on the other hand, is a complex aromatic compound that is resistant 
to degradation by microorganisms [41]. Due to its recalcitrance, the lignin fraction is often 
discarded or burned to produce process heat or on-site electricity generation [42]. However, 
techno-economic analyses have identified the co-utilization of lignin as an important factor for the 
production of cost effective biofuels [43]. To aid in lignin degradation, lignin is often 
thermochemically depolymerized, resulting in toxic xenobiotics such as vanillic acid, catechol, 
carboxylic acids, and phenolic compounds that inhibit bioconversion [40, 41]. Research is 
currently underway to engineer a microbial strain, either through adaptive evolution or rational 
design, that is tolerant of and can degrade these xenobiotic compounds, thus increasing 
bioconversion productivity and yield [44]. 
My first objective in this thesis was to characterize the evolution of xenobiotic tolerance in 
a single bacterial strain after several generations of adaptive evolution to aromatic compounds. To 
evaluate this, we conducted adaptive evolution on Rhodococcus opacus PD630 (hereafter R. 
opacus) over several generations using various lignin-derived model compounds. R. opacus is a 
soil bacteria isolated from contaminated soil at a gasworks plant that has a naturally high tolerance 
for aromatic compounds [45]. Through adaptive evolution we increased the xenobiotic tolerance 




genomics of these adapted strains compared to the wild type strain, we identified genetic mutations 
and changes in gene expression levels that contribute to xenobiotic tolerance at the strain level. 
1.5 Antibiotic Resistance in Gut Microbial Communities 
 
Not all xenobiotic tolerance is useful from an anthropogenic viewpoint. Microbial 
resistance to antibiotics is quickly becoming a major public health problem [46]. Even though 
antibiotic resistance pre-dates mass production of antibiotics, widespread use of antibiotics has 
selected for an increased abundance of antibiotic resistance genes (ARGs) in environmental and 
human microbiomes [47-50].  Antibiotic resistance in bacteria is particularly troubling due to the 
fact that adaptive evolution is working against us, i.e. extensive treatment with antibiotics results 
in a higher abundance of ARGs and increased tolerance [51]. Thus, the only way to combat 
antibiotic resistance, besides continually designing new families of antibiotics, is to prevent the 
spread of plasmid-borne ARGs and develop ARG inhibitors that can rescue antibiotic potency 
[52]. Identifying ARGs before they are acquired and widely disseminated by pathogens is crucial 
to this effort and provides much needed time to develop ARG inhibitors [53, 54].  
 The second objective of my thesis was to examine the gut microbial community in humans 
and great apes along a gradient of Westernization. We compared the gut microbiome and resistome 
of wild chimpanzees and gorillas living in Nouabalé-Ndoki National Park in the Republic of the 
Congo, humans living just outside the park, and captive chimpanzees and gorillas from the St. 
Louis Zoo (USA) and the Lincoln Park Zoo (Chicago, USA). With this cohort we can investigate 
the differences in taxonomy and the abundance and richness of ARGs that occur in the gut 
microbiome in cohorts with and without antibiotic exposure. Finally, by using functional 
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2.1 Abstract  
 
Lignin utilization has been identified as a key factor in biorefinery profitability. However, 
lignin depolymerization generates heterogeneous aromatic mixtures that inhibit microbial growth 
and the conversion of lignocellulose to biochemicals. Rhodococcus opacus is a promising 
aromatic-catabolizing, oleaginous bacterium, but mechanisms for its aromatic tolerance and 
utilization remain undercharacterized. To better understand these mechanisms, we adaptively 




Evolved R. opacus mutants showed up to 1900% growth improvement in the utilization of phenol, 
guaiacol, 4-hydroxybenzoate, vanillate, and benzoate compared to the wild-type strain. Whole 
genome sequencing revealed several redox-related genes with mutations shared across multiple 
adapted mutants. PVHG6, the mutant with the most improved growth on a mixture of multiple 
aromatic compounds, showed 56% lower superoxide dismutase activity than the wild-type strain, 
suggesting that redox reactions are important for aromatic tolerance and utilization. Comparative 
transcriptomics revealed by-product detoxification pathways and five aromatic funneling 
pathways that were upregulated in response to specific aromatic compounds. Gene knockout 
experiments confirmed the two degradation routes of the β-ketoadipate pathway for five aromatic 
compounds. These results provide an improved understanding of aromatic bioconversion and 
facilitate development of R. opacus as a biorefinery host. 
2.2 Introduction 
 
Lignocellulosic biomass is a potential source of renewable bio-based fuels and chemicals. 
A large fraction of lignocellulose (~ 70–85%) is cellulose and hemicellulose, which can be 
depolymerized into monomeric sugars, such as glucose and xylose [55, 56]. The remaining 15–
30% of lignocellulose is lignin, a highly cross-linked, heterogeneous, and recalcitrant aromatic 
polymer [57]. Microbial conversion of lignocellulose holds promise as a new way to produce a 
variety of novel products and petrochemical replacements (e.g., drop-in fuels) [58-67]. Current 
biomass pretreatment approaches, which aim to increase sugar extractability from lignocellulose, 
also release aromatics from lignin that negatively affect microbial product titers, yields, and 
productivities [41, 68]. Current processes separate the carbohydrate fraction from the lignin 
fraction, and the separated lignin is either discarded or burned for process heat or on-site electricity 




challenging and costly, and techno-economic analyses have identified the co-utilization of lignin 
as an important factor in biorefinery profitability [43, 70]. Therefore, efforts are underway to 
develop microbial strains that can tolerate and convert inhibitory, lignin-derived compounds into 
value-added products [71-80].  
Rhodococcus opacus PD630 (hereafter R. opacus) is a promising bacterial strain for 
producing valuable products from lignocellulose. R. opacus is a gram-positive soil bacterium that 
has been shown to have an inherently high tolerance to aromatic compounds [45, 81]. Additionally, 
it accumulates high levels (up to ~78% as cell dry weight) of the biofuel precursor triacylglycerol 
(TAG) and demonstrates a moderately high growth rate [45, 82]. R. opacus can natively consume, 
or has been engineered to consume, hexose and pentose sugars present in lignocellulosic 
feedstocks [82, 83]. R. opacus can also consume aromatic compounds found in depolymerized 
lignin, such as phenol, 4-hydroxybenzoate, and vanillate [84-86], making it uniquely qualified to 
utilize all three primary depolymerized components of lignocellulose.  
The co-consumption of mixtures of lignin-derived aromatic monomers is an underexplored 
area of study that is important for microbial lignin conversion strategies. The inherent 
heterogeneity of lignin is a major barrier to lignin valorization, and economical strategies require 
rapid conversion of complex aromatic mixtures to products [87-90]. Microbial degradation of 
diverse aromatic compounds is typically accomplished by biological funneling, where compounds 
are converted into common metabolites (e.g., catechol and proto-catechuate), prior to their 
catabolism via a central aromatic degradation pathway, such as the β-ketoadipate pathway [87, 
91]. However, interactions between similarly structured compounds and different aromatic 
degradation pathways are not well understood in bacteria. Additionally, cross tolerance between 




concentrations of multiple inhibitory compounds can negatively affect bacterial growth more than 
high concentrations of a single inhibitory compound on its own [92].  
The underlying mechanisms for aromatic tolerance and utilization in R. opacus, and 
microbes in general, are not well understood due to the complexity of the phenotype, which limits 
the use of rational strain engineering. One methodology for improving aromatic tolerance is 
through adaptive evolution, where evolutionary selection pressure is applied to the organism 
through serial subcultures [93, 94]. R. opacus has been demonstrated to be amenable to adaptation 
for improved growth in the presence of different inhibitors from lignocellulosic hydrolysates (e.g., 
furans, organic acids, and phenolics) [92], but the mechanistic basis for these improvements are 
unknown. Our previous work showed that R. opacus could be adapted for improved growth and 
lipid production on the lignin model compound phenol as a sole carbon source [86], and we 
identified the upregulation of aromatic degradation pathways and transporters as potential 
mechanisms of improvement in the adapted strains. However, phenol is only one of many potential 
aromatic compounds from lignin [88-90], and additional research is required to understand R. 
opacus’ ability to adapt to mixtures of lignin-derived model compounds. 
In this work, R. opacus was adaptively evolved on 32 combinations of six lignin model 
compounds (without added sugars) to study the capacity to improve its aromatic tolerance and 
utilization (Figure 2-1). Comparative genomic analysis of 35 improved adapted strains identified 
a high percentage of mutations in oxidation and reduction (redox) related genes, several of which 
were shared across multiple strains from different adaptation conditions. We demonstrated that the 
activity of one of these targeted enzymes, superoxide dismutase, was 56% lower in PVHG6  (a 
mutant adapted for improved growth on a mixture of multiple compounds) than the wild-type 




and utilization. To examine whether aromatics were consumed individually or concurrently, 
targeted metabolomics was performed, revealing that compounds were consumed in a distinct 
order and that the PVHG6 strain co-consumed lignin model compounds at faster rates than the WT 
strain. We performed RNA-Seq on PVHG6 and WT grown on individual lignin model compounds 
and their mixture (without added sugars) to elucidate genes and pathways related to aromatic 
catabolism. Transcriptomic analyses identified five distinct funneling pathways and two by-
product detoxification pathways, each of which is activated by specific aromatic compounds, as 
well as a number of upregulated transporters. Additionally, by gene knockout experiments, we 
confirmed the degradation routes of five aromatic compounds and the importance of upregulated 
Figure 2-1: Experimental Approach. (A) R. opacus PD630 was serially passaged on lignin 
model compounds and high glucose (33 conditions). Six adapted cultures were selected for further 
characterization: four using phenol and up to three other lignin model compounds, one using 
sodium benzoate, and one using high glucose as carbon sources. (B) Six colonies from the selected 
adapted cultures were phenotyped in adaptation growth conditions to determine improvement 
compared to the WT strain. Strains with improved growth (OD600) compared to the WT strain were 
characterized by whole genome sequencing and growth assays using mixtures of lignin model 
compounds. (C) The best-performing adapted strain (PVHG6) and the WT strain were further 
characterized using RNA-Seq and targeted metabolomic analyses to identify mechanisms for 
improved lignin model compound tolerance and utilization. Lipid titers were measured to 





transporters for growth on aromatic compounds. Lastly, to demonstrate that our improved aromatic 
tolerance and utilization phenotypes are compatible with production of valuable products from 
lignin, we measured lipid production and observed a 225% increase in lipid titer with the PVHG6 
strain relative to the WT strain when grown on 2.5 g/L total aromatics as a sole carbon source. 
Together, these results advance our understanding of aromatic mixture tolerance and catabolism, 
which is a critical first step toward future fuel and chemical production from lignocellulose and 
establish R. opacus as a promising bioproduction strain. 
 
2.3 Results 
2.3.1 Adaptive evolution and characterization of adapted strains 
 
To determine R. opacus’ ability to improve its aromatic tolerance and consumption, we 
adaptively evolved it using increasingly higher concentrations of individual lignin model 
compounds and combinations of lignin model compounds (a total of 32 conditions without added 
sugars, Figure 2-1, Table 2-S1). For comparison to aromatic adaptation experiments, we also 
serially passaged R. opacus using high concentrations of glucose. For further analysis, we selected 
four adaptation experiments that used one to four different lignin model compounds that included 
phenol and other phenolic compounds as carbon sources, as well as two adaptation experiments 
that used sodium benzoate (a non-phenolic lignin model compound) and glucose as sole carbon 
sources. The adaptation experiments chosen for further characterization were:1) phenol (P); 2) 
phenol and vanillate (PV); 3) phenol, vanillate, and 4-hydroxybenzoate (PVH); 4) phenol, 
vanillate, 4-hydroxybenzoate, and guaiacol (PVHG); 5) sodium benzoate (B); and 6) high glucose. 
Six colonies from each of these six chosen adaptation experiments were isolated, and their growth 




2-2, 2-S1). 35 of the 36 isolated strains had significantly higher cell densities (OD 600; up to1900% 
improvement) than the WT strain after 43 h of growth on the carbon sources used in their 
adaptation. Aromatic consumption pat-terns for adapted strains after 43 h of growth suggest that 
improved growth of these strains is due to both consumption of and tolerance to aromatic carbon 
sources (Figure 2-S2). These results demonstrate that R. opacus can be adaptively evolved to 
improve growth on different combinations of lignin model compounds. 
 
Figure 2-2: Growth of the WT strain and adapted strains using adaptation carbon sources. 
Bars represent OD600 values measured at 43 h of growth in minimal medium A supplemented with 
the listed carbon sources and 1 g/L ammonium sulfate as the nitrogen source. (A) The PHE adapted 
strains (P1-6) compared to the WT strain using 1.1 g/L PHE. (B) The PHE and VAN adapted 
strains (PV1-6) compared to the WT strain using 1.2 g/L PHE and 1.2 g/L VAN. (C) The PHE, 
VAN, and HBA adapted strains (PVH1-6) compared to the WT strain using 0.5 g/L PHE, 1 g/L 
HBA, and 1 g/L VAN. (D) The PHE, VAN, HBA, and GUA adapted strains (PVHG1-6) compared 
to the WT strain using 0.4 g/L GUA, 0.4 g/L PHE, 0.7 g/L HBA, and 0.7 g/L VAN. (E) The BEN 
adapted strains (B1-6) compared to the WT strain using 9.4 g/L BEN. (F) The high glucose adapted 
strains (Glc1-6) compared to the WT strain using 314 g/L glucose. Bars represent the average of 
three biological replicates and error bars represent one standard deviation. PHE = phenol, VAN = 




2.3.2 Comparative genomics of adapted strains 
 
To identify possible causative mutations for adaption, we examined the 35 isolated strains 
with improved growth (Figure 2-2) by whole genome sequencing (> 38× coverage per strain). 
Across all 35 strains, genomic analysis revealed a total of 255 distinct SNPs and 6 
insertion/deletions (INDELs) distributed over the chromosome and 6 of the 9 endogenous plasmids 
[95] (Figure 2-S3, Tables 2-S2–2-S4). Based on sequencing depth, we observed major deletions 
in Plasmid 1 for 11 strains from the PVHG, B, and high glucose adaptation experiments, and we 
observed complete loss of Plasmid 2 in 25 strains from the P, PV, PVH, PVHG, and B adaptation 
experiments (Figure 2-S4). Plasmids 1 and 2 are large plasmids with sizes of 172,218 bp and 
97,588 bp, respectively. Growth improvements could result from either deletion of burdensome 
genes, reduced replication costs for maintaining large plasmids, or a combination of both [96, 97]. 
To identify potential common patterns of genetic changes between strains and adaptation 
conditions, we classified genes affected by mutations using Gene Ontology (GO) terms [98] and 
then further grouped GO terms into broader functional categories (Figure 2-3A). Interestingly, 
many genes involved in redox reactions were affected by SNPs after adaptation in phenolic 
compound mixtures (Figure 2-3A). On average, 36% of the non-synonymous SNPs in strains 
adapted using phenolic compounds, compared to only 16% in strains adapted using non-phenolic 
carbon sources (e.g., BEN and glucose), were found in genes related to redox reactions. These 
results suggest that the selection pressure applied by adaptive evolution targeted redox reactions 
to improve tolerance and utilization of phenolic compounds.  
We identified seven genes that were affected by non-synonymous SNPs across multiple 
aromatic adaptation experiments (Figure 2-3B, Table 2-S5). Surprisingly, we did not observe any 





Figure 2-3: Comparative genomics of lignin model compound adapted strains. (A) 
Categorization of genes with non-synonymous SNPs or intergenic SNPs that could affect gene 
expression using Gene Ontology (GO) terms organized by strain. Strain names indicate the 
adaptation condition from which each strain originated: P = phenol; PV = phenol and vanillate; 
PVH = phenol, vanillate, and 4-hydroxybenzoate; PVHG = phenol, vanillate, 4-hydroxybenzoate, 
and guaiacol; B = sodium benzoate; and Glc = glucose. (B) Genes with non-synonymous SNPs or 
intergenic SNPs that could affect gene expression and that were found across multiple aromatic 
adaptation experiments. Putative annotations are from NCBI reference sequence NZ_CP003949.1. 
“All” indicates that all sequenced strains isolated from the indicated adaptation condition contain 
either non-synonymous SNPs or intergenic SNPs that could affect gene expression. Base Mean 
Expression is the average of the normalized counts from WT and PVHG6 transcriptomic data from 
all growth conditions. 
are annotated to be involved in redox reactions: RS14825 (cytochrome ubiquinol oxidase subunit 
I), RS01890 (manganese-dependent superoxide dismutase [SOD]), and RS38570 (a FAD-binding 
oxidoreductase).  Non-synonymous or intergenic SNPs affecting cytochrome ubiquinol oxidase 
and superoxide dismutase were found in at least one strain from all four adaptation experiments 
containing phenolic compounds, but not in any strains from the B and high glucose adaptation 
experiments. The previous adaptation experiment in R. opacus using phenol [86] also led to a 




had non-synonymous SNPs in multiple adaptation lineages: RS08140 (phosphoenolpyruvate 
[PEP] carboxykinase) and RS10095 (class II fructose-bisphosphate aldolase). Additionally, two 
genes related to phosphorylation had non-synonymous SNPs: RS32480 (phosphotransferase) and 
RS39015 (serine/threonine protein kinase). 
To investigate the consequence of non-synonymous SNPs in the cytochrome ubiquinol 
oxidase and SOD genes further, we modeled the mutational sensitivity (i.e., the probability of the 
mutation having a phenotypic effect) using Phyre2 [99] and SuSPect [100]. The modified residues 
in the adapted strains for both genes had mutational sensitivities ranging from medium to very 
high for the modified amino acids, suggesting that these SNPs could have a phenotypic effect 
(either positive or negative; Tables 2-S6, 2-S7) [100]. To verify the modeling results for 
superoxide dismutase, we measured the SOD activity using cell lysates from the WT strain and 
one of our multi-compound adapted strains with a non-synonymous SNP in SOD (PVHG6). The 
adapted PVHG6 strain showed a 56% lower SOD activity compared to that of the WT strain 
(Figure 2-S5). This lower activity suggests that the adapted strain is likely to reduce fewer 
superoxide radicals than the WT strain, which could contribute to its improved growth in the 
mixture of lignin model compounds through their facilitated oxidation [101, 102]. 
2.3.3 Characterization of adapted strains on lignin model compound mixtures 
 
Efficient microbial lignin valorization requires the utilization of complex aromatic 
compound mixtures. Thus, we sought to determine the performance of our aromatic adapted strains 
in mixtures of lignin model compounds compared to the WT strain. We hypothesized that the 
adapted strains’ improved tolerance phenotype towards a subset of five chosen lignin model 
compounds (one to four compounds) could be extended to a mixture of all five compounds. To 




experiments on a mixture of five aromatics (PHE, GUA, HBA, VAN, and BEN). At 2.5 g/L total 
aromatics (0.5 g/L of each lignin model com-pound), all five adapted strains had significantly 
higher growth rates than the WT strain (P < 0.009 for all adapted strains; Figure 2-4A, Table 2-
S8). P1, PV1, and PVHG6 strains reached a higher OD600 than the WT strain after 100 h of growth 
(P < 0.004 for all three strains), while PVH5 and B2 did not reach significantly higher OD600 values 
(Table 2-S8). PVHG6 reached the highest OD600 among all strains after 70 h of growth, which was 
96% higher than the WT strain (P = 3.8 × 10−6). At 3.0 g/L total aromatics (0.6 g/L of each 
aromatic compound), all strains had significantly higher growth rates than the WT strain (P < 0.03 
for all adapted strains; Figure 2-S6, Table 2-S9). P1, PV1, and PVHG6 also reached 75–85% 
higher OD600 values than the WT strain after 100 h of growth (P < 0.03 for all three strains), while 
PVH5 and B2 did not reach significantly higher OD600 values (Figure 2-S6, Table 2-S9). These 
results demonstrate that some adapted strains (P1, PV1, and PVHG6) have improved growth on a 
mixture of aromatics, some of which were not used during their adaptation. For the three best-
performing strains (P1, PV1, and PVHG6), the only exclusively shared gene which was affected 
by a SNP was SOD (Figure 2-3B), which further supports that SOD may be related to improved 
growth on lignin model compounds. Because PVHG6 showed the best growth performance at both 
2.5 and 3.0 g/L total aromatics, it was chosen for further characterization. 
2.3.4 Aromatic consumption in a lignin model compound mixture by PVHG6 
 
Next, we sought to determine if all lignin model compounds in the five-compound mixture 
were used for growth and if PVHG6 consumed aromatics in a similar manner to that of the WT 
strain. We used a targeted metabolomic approach to measure the concentration of each individual 
aromatic compound in the mixture (0.5 g/L of PHE, GUA, HBA, VAN, and BEN; 2.5 g/L total 





Figure 2-4: Growth and consumption of lignin model compounds by WT and adapted 
strains. Cells were grown in minimal medium A supplemented with the listed carbon sources and 
1 g/L ammonium sulfate as the nitrogen source. (A) Growth of one strain from each aromatic 
adaptation experiment and the WT strain in a mixture of lignin model compounds (0.5 g/L each of 
GUA, PHE, HBA, VAN, and BEN; 2.5 g/L total aromatics). (B) Aromatic consumption profiles 
of WT and PVHG6 strains in the same growth condition as A. Aromatic concentrations were 
measured by derivatizing culture supernatants using methyl chloroformate followed by GC-MS-
FID (see Section 2.5 for details). (C) Growth and consumption of individual aromatic compounds 
as a sole carbon source by WT and PVHG6 strains (aromatic concentrations listed above plots). 
Aromatic concentrations were estimated using UV absorbance (see Section 2.5 for details). Note 
that the y-axis scales for growth and concentration plots vary between carbon sources. For all plots, 
points represent the average of three biological replicates and error bars represent one standard 
deviation. PHE = phenol, VAN = vanillate, HBA = 4-hydroxybenzoate, GUA = guaiacol, and BEN 
= sodium benzoate. 
before PHE, GUA, and VAN. Both strains fully consumed BEN and HBA within 24–32 h, while 
consumption of PHE, GUA, and VAN began after 24 h for both strains. Within 60 h, all five 
compounds were almost fully consumed by the PVHG6 strain, but substantial amounts of PHE 




a 27% higher total aromatic consumption rate than the WT strain (52 mg/L/h for PVHG6 vs. 41 
mg/L/h for the WT strain from 0 to 44 h, P = 0.0024). Additionally, it was found that PVHG6 also 
consumed a mixture containing 3 g/L glucose and all five aromatic compounds (0.6 g/L of PHE, 
GUA, HBA, VAN, and BEN; 3 g/L total aromatics) as carbon sources, and it completely utilized 
all aromatics after 60 h of growth (Figure 2-S7). 
2.3.5 Consumption of individual aromatic compounds by PVHG6 
 
To determine whether the improved growth phenotype of PVHG6 on a mixture of lignin 
model compounds extended to individual compounds, we measured growth and aromatic 
concentrations using six different concentrations of PHE, VAN, HBA, GUA, and BEN as a sole 
carbon source (Figures 2-4C, 2-S8–2-S13). Aromatic concentrations were measured using UV 
absorbance. From these experiments, we calculated the half maximal inhibitory concentration 
(IC50) using OD600 values at 54 h. We only observed a significant increase in the IC50 value of 
PVHG6 compared to that of the WT strain when they were grown in PHE (17%, P = 0.003) and 
GUA (16%, P = 0.008) (Table 2-S10). The IC50 values of PVHG6 for HBA, VAN, and BEN were 
unchanged or slightly decreased (Table 2-S10). When 1 g/L glucose was used as a sole carbon 
source, no difference in growth was observed between the WT and PVHG6 strains (Figure 2-S14), 
implying that glucose metabolism was not affected by mutations during the long adaptation 
process in the absence of glucose. 
2.3.6 Transcriptomic analysis of WT and PVHG6 using lignin model 
compounds 
 
We had previously observed that changes in gene and pathway expression better explained 
improved phenol utilization phenotypes in evolved R. opacus strains, compared to the effect of 




determine the potential role of transcriptional differences in the improved tolerance and utilization 
of a larger panel of aromatics by the evolved PVHG6 strain. We performed whole cell gene 
expression profiling via RNA-Seq on the WT and PVHG6 strains grown in a mixture of all five 
lignin model compounds (0.5 g/L of each lignin model compound, 2.5 g/L total aromatics), or in 
1 g/L glucose, to identify differentially regulated genes between strains and carbon sources. We 
also performed RNA-Seq using 0.5 g/L of each of the five lignin model compounds individually 
(PHE, GUA, HBA, VAN, or BEN) to determine compound-specific degradation pathways for 
each compound. For the 1 g/L glucose (Glc) and the mixture of five lignin model compounds 
(hereafter, “mixture”), we analyzed the transcriptome at both the early and mid-exponential phases 
(20 h and 32 h for the mixture; 10 h and 13 h for Glc) since we had observed differential 
consumption rates of lignin model compounds in our targeted metabolomic analysis (Figure 2-
4B). 
To investigate differences in expression profiles between WT and PVHG6, we first 
analyzed all transcriptomic data for both strains using principal component analysis (Figure 2-
S15). PVHG6 and WT were clearly separated along the first principal component with values 
higher than 60 and lower than −50, respectively, while the second principal component generally 
separated transcriptional profiles by growth conditions. Permutational ANOVA (PERMANOVA) 
indicated that transcriptomic profiles between strains and between growth conditions were 
significantly different (P = 0.001, both cases). Based on our genome sequencing data, which was 
corroborated by our transcriptomic data (Figure 2-S4), many adapted strains, including PVHG6, 
underwent plasmid deletions and plasmid loss. We repeated the principal component analysis with 




of WT and PVHG6, the strains were still significantly different based on PERMANOVA (P = 
0.002; Figure 2-S16). 
We then compared the top 30 differentially upregulated genes between both strains grown 
in the mixture at both time points (Figure 2-S17).The most upregulated genes in PVHG6 relative 
to the WT strain in the mixture at both time points were RS27075 (a hypothetical protein, 41-fold 
upregulated) and RS13410 (a type VII secretion-associated protein, 40-fold upregulated), 
respectively. Five of the top 30 upregulated genes are annotated as ABC transporters or ABC 
transporter associated proteins, suggesting that these ABC transporters might control uptake or 
export rates of aromatic compounds. Two genes annotated as acetyl-CoA acetyltransferases 
(RS34095 and RS34105) were also in the top 30 list. Both proteins share high positive amino acid 
sequence similarity to 3-oxoadipyl-CoA thiolases in R. opacus and R. jostii RHA1 (52–76% 
positive identity, Table 2-S11). The final step in the β-ketoadipate pathway is catalyzed by 3-
oxoadipyl-CoA thiolase, converting 3-oxo-adipyl-CoA into succinyl-CoA and acetyl-CoA. 
RS34095 and RS34105 may encode this enzyme, acting as additional gene copies and increasing 
the metabolic flux through the β-ketoadipate pathway in PVHG6 when the aromatic mixture is 
used. 
To identify putative funneling pathway enzymes for each lignin model compound, we 
searched for the most strongly upregulated enzymes when both strains were grown in the 
individual aromatic compounds and the mixture, compared to the glucose condition (Figure 2-5A). 
These selected proteins were then compared to homologous enzymes in a closely-related strain, R. 
jostii RHA1, which has a characterized proteome [103] (Table 2-S12). Using this process, we 
identified funneling pathway clusters for each lignin model compound:  two  two-component  




demethylase (RS02665–RS02675), a putative 4-hydroxybenzoate monooxygenase (RS31675), 
two putative cytochrome P450 clusters upregulated in response to GUA (RS30780–RS30785 
[GUA degradation cluster #1] and RS21470–RS21485 [GUA degradation cluster #2]), and a 
putative benzoate degradation cluster (RS30790–RS30805). Many of these funneling pathway 
enzymes have high sequence similarity to biochemically characterized pathway enzymes in other 
Rhodococcus strains, including R. opacus 1CP (Table 2-S12) [104, 105]. Each of these genes or 
gene clusters converts lignin model compounds to either catechol (CAT) or protocatechuate (PCA) 
for subsequent degradation by the β-ketoadipate pathway (Figure 2-6B). All of these genes were 
upregulated in both the individual aromatic condition and the mixture compared to glucose, except 
GUA degradation cluster #2 which was upregulated in GUA but not upregulated in the mixture 
compared to glucose (Figure 2-5A). This differential expression suggests transcriptional regulation 
(i.e., repression) of this funneling pathway in response to the presence of other lignin model 
compounds. When the expression of the identified funneling pathways in PVHG6 was compared 
to the WT strain in the mixture, most genes at both time points were not differentially expressed 
with the exception of the benzoate degradation pathway at the second time point, which was 29–
95-fold downregulated (adjusted p-values < 7 × 10−29). Our metabolomic data (Figure 2-4B) 
showed that PVHG6 completely consumed BEN after 24 h (compared to 32 h for WT), which 
suggests that the BEN funneling pathway genes were downregulated in PVHG6 in response to 
complete consumption of BEN. For other funneling pathways, no genes were more than 2.6-fold 
upregulated or downregulated in PVHG6 compared to the WT strain at either time point in the 
mixture. 
The funneling pathways convert aromatic compounds into two intermediates, CAT or 




Rhodococcus strains suggest that VAN and HBA are converted to PCA, while GUA, BEN, and 
PHE are converted to CAT [106]. For both WT and PVHG6, we observed upregulation of β-
ketoadipate gene cluster #1 (RS25340–RS25375) compared to the glucose condition for all 
aromatic carbon sources (Figure 2-6A). This gene cluster includes genes required to convert both 
CAT and PCA into central tricarboxylic acid (TCA) cycle metabolites.  In both strains, β-
ketoadipate gene cluster #2 (RS31565–RS31575) was upregulated in PHE and the mixture (up to 
5000-fold), but it was upregulated only up to 3-fold in other lignin model compounds compared 
to the glucose condition. This observed upregulation could be related to the upstream phenol 
hydroxylase (RS31555–RS31560 in the phenol funneling pathway; Figure 2-5A) that is highly 
upregulated in PHE compared to the glucose condition. We also observed upregulation of β-
ketoadipate gene cluster #3 (RS30720–RS30745) during growth on all aromatic carbon sources. 
In both strains, genes in this cluster, which is typically associated with degradation of CAT 
intermediates, were highly upregulated (142–779-fold) by CAT branch compounds (GUA, BEN, 
and PHE) relative to the glucose condition, but they were only moderately upregulated (9–93-fold) 
by PCA branch compounds (VAN and HBA) relative to the glucose condition. Interestingly, such 
a branch-dependence was also observed in regulation of some funneling enzymes (Figure 2-5A). 
For example, a phenol hydroxylase (RS30765–RS30770) was also highly upregulated in GUA 
(121–477-fold), but minimally upregulated by PCA precursors VAN and HBA (up to 5.9-fold), 
compared to the glucose condition in both strains. The putative vanillate demethylase (RS02665–
RS02675) was also upregulated in HBA (114–295-fold), but minimally upregulated by CAT 
precursors GUA and BEN (1.4–2.2-fold) in both WT and PVHG6, compared to the glucose 
condition. When compared to the WT strain in the mixture, PVHG6 did not show substantial 




previously characterized R. opacus mutants that were adapted using a single compound (PHE) and 
that showed large differential upregulation of a number of phenol degradation genes in PHE 
compared to the WT strain [86].  
 
Figure 2-5: Activation of lignin model compound funneling pathways in R. opacus. (A) Heat 
map of normalized expression counts for upregulated aromatic degradation genes that convert (i.e. 
“funnel”) lignin model compounds to the β-ketoadipate pathway during growth on individual 
lignin model compounds, a mixture of lignin model compounds, and glucose. Raw counts were 
transformed using the variance stabilizing transformation in DESeq2. Darker colors indicate 
higher normalized counts (see scale bar). Glc = 1 g/L glucose, PHE = 0.5 g/L phenol, VAN = 0.5 
g/L vanillate, HBA = 0.5 g/L 4-hydroxybenzoate, GUA = 0.5 g/L guaiacol, BEN = 0.5 g/L sodium 
benzoate, and Multi = 0.5 g/L of PHE, VAN, HBA, GUA, and BEN (2.5 g/L total aromatics). t1 
represents cells harvested at early exponential phase (10 h for Glc; 20 h for Multi), while t2 
represents cells harvested at mid-exponential phase (13 h for Glc; 32 for Multi). Samples from 
individual compound growth conditions were harvested at mid-exponential phase (24 h for WT 
PHE, 21 h for PVHG6 PHE, 19 h for WT and PVHG6 GUA, 11 h for WT and PVHG6 HBA, 12 
h for WT and PVHG6 BEN, 24 h for WT and PVHG6 VAN). Cells were grown in minimal 
medium A. Each square on the heat map represents a biological replicate. (B) Pathway map 
showing genes involved in lignin model compound funneling pathways in R. opacus. Gene codes 






Figure 2-6: Activation of β-ketoadipate pathway gene clusters by lignin model compounds in 
R. opacus. (A) Heat map of normalized gene expression counts for β-ketoadipate pathway gene 
clusters during growth on individual lignin model compounds, a mixture of lignin model 
compounds, and glucose. Raw counts were transformed using the variance stabilizing 
transformation in DESeq2. Darker colors indicate higher normalized counts (see scale bar). Glc = 
1 g/L glucose, PHE = 0.5 g/L phenol, VAN = 0.5 g/L vanillate, HBA = 0.5 0.5 g/L 4-
hydroxybenzoate, GUA = 0.5 g/L guaiacol, BEN = 0.5 g/L sodium benzoate, and Multi = 0.5 g/L 
of PHE, VAN, HBA, GUA, and BEN (2.5 g/L total aromatics). t1 represents cells harvested at 
early exponential phase (10 h for Glc; 20 h for Multi), while t2 represents cells harvested at mid-
exponential phase (13 h for Glc; 32 h for Multi). Samples from individual compound growth 
conditions were harvested at mid-exponential phase (24 h for WT PHE, 21 h for PVHG6 PHE 19 
h for WT and PVHG6 GUA, 11 h for WT and PVHG6 HBA, 12 h for WT and PVHG6 BEN, 24 
h for WT and PVHG6 VAN). Cells were grown in minimal medium A. Each heat map square 
represents a biological replicate. (B) Pathway map showing genes involved in β-ketoadipate 
pathway gene clusters in R. opacus. Gene codes are from the NCBI reference sequence 
NZ_CP003949.1. (C) Difference between initial OD600 and final OD600 after 24 h of growth for 
the RS30730 knockout (∆CAT) strain and the WT strain using different carbon sources. (D) 
Difference between initial OD600 and final OD600 after 24 h of growth for the RS25360 knockout 
(∆PCA) strain and the WT strain using different carbon sources. For C and D, the WT, ∆CAT, and 
∆PCA strains were initially cultured in 2 mL of minimal medium B containing 1 g/L ammonium 
sulfate, 4 g/L glucose, and either no aromatic compound, 0.2 g/L PHE, 0.25 g/L GUA, 0.5 g/L 
HBA, 0.25 g/L VAN, or 0.5 g/L BEN. Cells were then centrifuged, washed with minimal medium 
B containing no carbon source, and re-suspended to an initial OD600 of 0.2 in 10 mL of minimal 
medium B containing 1 g/L ammonium sulfate and either 1 g/L glucose, 0.4 g/L PHE, 0.5 g/L 
GUA, 1.0 g/L HBA, 0.5 g/L VAN, or 1 g/L BEN as sold carbon sources. Asterisk (*) indicates 
that the difference between initial and final OD600 values is less than one standard deviation. Bars 




To confirm whether the five tested aromatic compounds (PHE, GUA, HBA, VAN, and 
BEN) were catabolized via the CAT or PCA branch of the β-ketoadipate pathway, critical genes 
from both branches were knocked out, and growth assays were performed. β-ketoadipate gene 
cluster #3, which contains the CAT degradation pathway, was knocked out by a disruption of 
RS30730 (cis,cis-muconate cycloisomerase; ΔCAT), while β-ketoadipate gene cluster #1, which 
contains the PCA degradation pathway, was knocked out by a disruption of RS25360 (3-carboxy-
cis,cis-muconate cycloisomerase; ΔPCA). The knockout of the PCA degradation pathway was 
complicated by the fact that other central β-ketoadipate pathway genes required for CAT 
degradation are located further downstream in β-ketoadipate gene cluster #1 (Figure 2-6). To 
ensure transcription of those downstream genes, a constitutive promoter was integrated into the 
genome. The ΔCAT strain was unable to grow using PHE, GUA, and BEN as sole carbon sources, 
while the ΔPCA strain was unable to grow using HBA and VAN as sole carbon sources (Figures 
2-6C,D). Together, these results confirm that PHE, GUA, and BEN are funneled through the CAT 
branch, and HBA and VAN are funneled through the PCA branch of the β-ketoadipate pathway in 
R. opacus. 
Transporter expression control may be related to aromatic tolerance mechanisms. The 
putative shikimate transporter (RS31355), which was significantly upregulated in other phenol-
adapted R. opacus strains [86], was also upregulated in PHE (281–299-fold) and the mixture (87–
295-fold) for both WT and PVHG6 relative to the glucose condition at both time points. An MFS 
transporter (RS33590) was moderately upregulated in response to PCA precursors VAN (137–
193-fold) and HBA (10–15-fold), and the mixture (45–115-fold), but was minimally upregulated 
by CAT precursors PHE, GUA, and BEN (1.0–3.7-fold) in WT and PVHG6 at both time points. 




upregulated in BEN (1330–1720-fold) and the mixture (958–2620-fold) for both WT and PVHG6 
at the first timepoint. At the second time point, the MFS transporter was down-regulated in PVHG6 
compared to the WT strain in a similar manner to the BEN degradation cluster (Figure 2-5A). The 
MFS transporter RS30810 was also moderately upregulated by CAT precursor GUA (57–62-fold), 
but only minimally upregulated by PCA precursors VAN (1.6–7.5-fold) and HBA (1.1–8.7-fold) 
in both strains compared to the glucose condition. The branch-dependent upregulation of MFS 
transporters RS33590 and RS30810 is similar to what was observed for the β-ketoadipate pathway 
(Figure 2-6). Overall, we observed multiple transporters whose expression was responsive to lignin 
model compounds. 
To explore the role of transporters in aromatic tolerance and utilization, we compared the 
growth of three putative transporter knockout mutants (RS31355, RS33590, and RS30810) to that 
of the WT strain using different carbon sources (Figure 2-S18). The growth of these knockout 
mutants and the WT strain were compared using 0.75 g/L PHE, 1.25 g/L GUA, 1.75 g/L VAN, 2 
g/L HBA, 5 g/L BEN, and the combined mixture (2.5 g/L total aromatics) as sole carbon sources. 
The putative shikimate transporter (RS31355) knockout mutant had lower cell densities (OD600) 
after 48 h than the WT strain using PHE and the mixture as sole carbon sources, which matches 
previous reports of RS31355 having a role in PHE transport [86]. The putative vanillate transporter 
(RS33590) knockout mutant had lower OD600 values than the WT strain using VAN, PHE, and the 
mixture as sole carbon sources. The putative benzoate transporter (RS30810) knockout mutant had 
lower OD600 values than the WT strain using BEN, VAN, GUA, PHE, and the mixture as sole 
carbon sources (Figure 2-S18). None of the transporter knockout mutants exhibited growth 
impairments on HBA (Figure 2-S18). The impaired growth of the putative aromatic transporter 




of aromatic compounds plays an important role in aromatic tolerance and utilization (Figure 2-
S18). 
The consumption of aromatics can lead to the formation of by-products. We observed 
upregulation of gene clusters involved in one carbon compound (C1) metabolism during growth 
on aromatics (Figure 2-S19). Catabolism of VAN and GUA requires a demethylation step that 
releases formaldehyde during conversion to PCA and CAT, respectively [107-109] (Figures 2-5, 
2-6). In VAN and GUA growth conditions, we observed the upregulation of a mycothiol-
dependent pathway that converts formaldehyde to CO2, and this pathway is found in Rhodococcus 
strains and other actinomycetes [110, 111] (Figure 2-S19). This pathway (RS31920–RS31930) 
was upregulated in VAN and GUA (21–105-fold), but expression varied in the mixture from no 
significant upregulation to 26-fold upregulation for both strains compared to the glucose control. 
Another pathway for formaldehyde degradation is the ribulose mono-phosphate (RuMP) pathway, 
which converts formaldehyde and ribulose-5-phosphate to fructose-6-phosphate for consumption 
via the pentose phosphate pathway [112]. The RuMP pathway (RS21455–RS21460) was 
upregulated in VAN and GUA (450–2600-fold) compared to the glucose condition in both the WT 
strain and PVHG6. In the mixture, the RuMP pathway was upregulated in the WT strain (23–135-
fold) and PVHG6 (3–172-fold) relative to the glucose condition. Genes in the RuMP pathway are 
also located near the pentose phosphate pathway operon, which was upregulated in a similar 
pattern to the RuMP pathway (Figure 2-S19). Together, these results suggest that R. opacus has 
multiple formaldehyde degradation pathways which are activated only when they are necessary 
(e.g., when VAN or GUA is catabolized, generating the toxic by-product). 
To better understand the effect of mutations on the improved growth phenotype of PVHG6, 




mutations found in multiple adaptation conditions (Figures 2-S20, 2-S21). Of the genes with 
mutations in PVHG6, SOD (RS01890), non-ribosomal peptide synthetase (RS13070), and 
cytochrome ubiquinol oxidase (RS14825) were highly expressed (> 500 normalized counts) in 
both the WT and PVHG6 strains across all tested growth conditions, including the high glucose 
condition (Figure 2-S20). For genes with mutations found across multiple adaptation conditions 
(Figure 2-3B, Table 2-S5), SOD (RS01890), cytochrome ubiquinol oxidase (RS14825), 
phosphoenolpyruvate carboxykinase (RS08140), and fructose bisphosphate aldolase (RS10095) 
were highly expressed (> 500 normalized counts, Figure 2-S21). These results suggest that 
mutations could play a role in phenotypic differences between WT and PVHG6 strains, possibly 
by changing specific enzyme activities (e.g., SOD, Figure 2-S5), instead of changing expression 
levels of highly expressed genes (Figures 2-S20, 2-S21). 
2.3.7 Lipid production using lignin model compounds 
 
To determine the effect of the adaptation on the ability of R. opacus to convert lignin model 
compounds into a bioproduct (e.g., lipids), we compared total lipid production between WT and 
PVHG6 grown in 2.5 g/L of lignin model compounds (0.5 g/L each of PHE, GUA, HBA, VAN, 
and BEN) in minimal medium A in a low nitrogen condition (Figure 2-7). PVHG6 reached a 50% 
higher cell density (OD600) than the WT strain after 72 h, and it accumulated 44% of its cell dry 
weight as lipids, compared to only 26% by WT (Figure 2-7). After 72 h, the adapted strain reached 
a lipid titer of 0.13 g/L using lignin model compounds as a sole carbon source, which is a 225% 
increase compared to the WT strain (Figure 2-7B). These results suggest that adaptive evolution 
can lead to significant improvements in lipid production by increasing lignin model compound 






Figure 2-7: Conversion of lignin model compounds to lipids. (A) Growth of WT and PVHG6 
strains in low nitrogen conditions using minimal medium A with 0.5 g/L of PHE, VAN, HBA, 
GUA, and BEN (2.5 g/L total aromatics) as carbon sources and 0.125 g/L ammonium sulfate as 
the nitrogen source. (B) Lipid content and lipid titer of WT and PVHG6 strains after 72 h of growth 
in the same growth conditions as A. For all plots, points and bars represent the average of three 
biological replicates and error bars represent one standard deviation. Asterisk (*) indicates that the 
difference between WT and PVHG6 values is statistically significant (P < 0.05, one mean, two-




Microbial tolerance and consumption of aromatic mixtures is a complex, understudied 
phenotype that involves numerous interactions between many genes and pathways. An improved 
understanding of this complex phenotype and its underlying mechanisms is critical for efficient 
lignin valorization. In this work, we investigated lignin model compound tolerance and utilization 
by combining adaptive evolution and multi-omic approaches. We demonstrated that R. opacus can 
be adaptively evolved to improve consumption of aromatic mixtures, and we identified shared 
mutations in adapted strains from multiple adaptation experiments that could affect aromatic 
tolerance and utilization. We observed that the adapted strain PVHG6 had higher aromatic 
consumption rates than the WT strain in a mixture of lignin model compounds, and we identified 
five upregulated funneling pathways and two by-product detoxification pathways that were 
responsive to specific lignin model compounds. Furthermore, our results demonstrate that 




likely play an important role in aromatic tolerance and utilization. Overall, this work highlights 
the value of combining adaptive evolution with a multi-omic approach to provide insights into 
microbial aromatic tolerance and utilization, to create improved strains for aromatic mixture 
consumption, and to identify novel targets for engineering R. opacus strains toward lignin 
valorization. 
The ability of R. opacus to successfully adapt to a mixture of lignin model compounds in 
a relatively small number of generations could be related to its relatively high mutation rate. Across 
all adaptation experiments, we observed an average of 32 mutations after ~ 270–420 generations 
(~ 4 generations per subculture) (Table 2-S1), which is at least an order of magnitude higher than 
rates of occurrence observed in Escherichia coli under stress conditions [113]. Even in the high 
glucose condition, the average mutation occurrence was 19 mutations after ~ 290 generations in 
R. opacus. This high occurrence of mutations was not the result of any mutations in the DNA 
recombination and repair system, which are often found in hypermutator strains [114-116]. 
Notably, a large portion of SNPs observed in R. opacus were synonymous SNPs (Table 2-S2). 
While synonymous SNPs could potentially affect gene expression rates, protein folding, and thus 
protein functions [117], most synonymous SNPs in both the glucose and aromatic adaptation 
conditions were located in the same region of Plasmid 1, suggesting that these mutations are not 
related specifically to aromatic tolerance and utilization. 
The most frequently mutated genes in R. opacus were related to redox reactions (Figure 2-
3B). One such example was SOD, a highly conserved enzyme that protects cells from superoxide 
radicals (O2
-) by converting them into molecular oxygen (O2) or hydrogen peroxide (H2O2) [118]. 
We also observed multiple mutations affecting cytochrome ubiquinol oxidase in all phenolic 




mutated in a previous R. opacus adaptation experiment using phenol as a sole carbon source [86]. 
Cytochrome ubiquinol oxidase catalyzes the terminal step in one of the electron transport chains 
present in Rhodococcus strains, which reduces O2 to H2O [119]. The exact mechanistic 
contribution of these two mutated enzymes to the evolved aromatic phenotypes is not fully 
understood, but the known utilization of superoxide radicals and O2 during aromatic consumption 
may provide some insights. Super-oxide radicals are generated from O2 by aromatic degradation 
enzymes, including monooxygenase funneling enzymes (e.g., HBA mono-oxygenase) [102] and 
ring splitting dioxygenases (e.g., catechol 1,2-dioxygenase) [101], to facilitate aromatic 
catabolism. Our observation that PVHG6 had a 56% decreased SOD activity relative to the WT 
strain suggests a greater availability of superoxide radicals for aromatic degradation enzymes in 
PVHG6 than the WT strain. 
By performing transcriptomic analyses on strains grown on single compounds, we were 
able to identify distinct funneling pathways for five lignin model compounds (Figure 2-5) and two 
aromatic by-product detoxification pathways (Figure 2-S19). The responses of funneling pathways 
to individual compounds and the mixture (Figure 2-5A), together with a distinct consumption 
pattern of lignin model compounds in the mixture (Figure 2-4B), suggest that R. opacus can 
differentially and specifically regulate aromatic utilization pathways in response to specific 
compounds. Carbon catabolite repression in Rhodococcus strains has been reported between 
aromatic compounds such as benzoate and phthalate [120] and 4-methoxybenzoate and 2-
ethoxyphenol [121]. Relatedly, we observed differential upregulation of guaiacol degradation 
cluster #2 between the GUA growth condition and the mixture in both WT and PVHG6 strains 
(Figure 2-5A), suggesting that the presence of other aromatic compounds may delay guaiacol 




Additionally, two pathways for a by-product of VAN and GUA catabolism, formaldehyde, in 
addition to the gluconeogenesis and pentose phosphate pathway genes that produce required 
enzymatic substrates, were all upregulated in both strains in the VAN, GUA, and mixture growth 
conditions (Figure 2-S19). Several transporter genes were also upregulated, and gene knockout 
experiments demonstrated their importance for aromatic utilization or tolerance, as suggested 
previously [86]. Together, these results show that R. opacus encodes a complex catabolic network 
for aromatic utilization, which includes a number of aromatic transporters and metabolic pathways 
that are regulated in a compound-specific manner. 
In our previous report, we performed adaptive evolution using phenol as a sole carbon 
source [86]. Because lignin depolymerization generates heterogeneous aromatic mixtures, 
understanding tolerance and utilization mechanisms for a greater diversity of aromatic compounds 
and mixtures is necessary for lignin valorization. Accordingly, our current work tackles a 
substantially expanded set of adaptive evolution experiments on multiple lignin model compounds 
(including phenol) and their mixtures. From this large number of evolved trajectories, we chose 
six adaptive evolution experiments which represented both substrate diversity and mixture 
complexity and performed comparative multi-omic analyses of selected mutant strains that were 
grown in these diverse aromatic carbon sources. Our comprehensive, multi-omic analyses allowed 
for elucidation of improved aromatic catabolism in evolved R. opacus strains as well as 
identification of multiple compound-specific pathways, facilitating future lignin valorization 
efforts. 
2.5 Materials and Methods 





Chemicals were purchased from Sigma Aldrich (St. Louis, MO) unless otherwise 
indicated, and Rhodococcus opacus PD630 (DSMZ 44193) was used as the ancestral strain (WT) 
for comparison to all mutated strains. For all growth experiments (unless otherwise indicated), 
cells were grown at 30 °C and 250 rpm in one of two defined minimal salts media (A or B; medium 
composition as previously described [106]). Culture media were filter-sterilized using a 0.22 μm 
filter, and pH was adjusted to 7.0 using 6 M HCl or 2 M NaOH. Carbon and nitrogen sources were 
added as sterile-filtered stock solutions. R. opacus strains were maintained on tryptic soy broth 
(TSB) plates supplemented with 1.5% agar. 
2.5.2 Adaptive evolution and growth assays of adapted strains 
 
R. opacus was serially passaged on combinations of protocatechuate (PCA), guaiacol 
(GUA), phenol (PHE), 4-hydroxybenzoate (HBA), and vanillate (VAN) as carbon sources, and it 
was also passaged on each compound individually (Figure 2-1). R. opacus was also adapted on 
sodium benzoate (BEN) and high concentrations of glucose individually as sole carbon sources. 
Minimal medium A was used for adaptation experiments. To start adaptation experiments, a single 
colony of the ancestral strain from a TSB agar plate was grown at 30 °C in 2 mL of minimal 
medium A supplemented with 0.3 g/L PHE for 24–48 h, followed by a subculture using an initial 
OD600 of 0.05 in 10 mL of the same media for 24 h. Next, cells were centrifuged at 3000 g for 10 
min and resuspended in minimal medium A without carbon or nitrogen sources, and adaptation 
experiments were performed at a 10 mL culture volume in a 50 mL glass culture tube with the 
corresponding carbon source(s) (Table 2-S1) and 1 g/L ammonium sulfate as the nitrogen source. 
For passaging, cultures were started at an initial cell density (OD600) of 0.03. After ~ 30 passages, 
the initial cell density was increased to 0.05 for all adaptation experiments. Cells were passaged 




each passage were stored at −80 °C in 15% glycerol. At each passage, the total aromatic 
concentration was increased by 1–5% until we did not observe growth after three days. If cells did 
not grow after three days, the culture was restarted from the previous −80 °C frozen stock, and the 
overall aromatic concentration was decreased until cell growth could be recovered. Once growth 
was recovered, the concentration was held constant for multiple passages before increasing 
concentrations in following passages. Adaptation experiments were stopped when we observed no 
growth after restarting adaptations from frozen stocks or adaptations reached > 100 passages. See 
Table 2-S1for details on adaptation experiments. 
To isolate colonies, adapted cultures were streaked on minimal medium plates 
supplemented with 1.5% agar, 1 g/L ammonium sulfate, and respective carbon sources from the 
adaptation experiment (concentrations as indicated in Table 2-S13). Six colonies were picked and 
grown at 30 °C in a 5 mL culture volume in a 50 mL glass tube with minimal medium A 
supplemented with 5 g/L glucose and 1 g/L ammonium sulfate for 36 h before storage at −80 °C 
in 15% glycerol. To compare the phenotype of the isolated colonies to that of the WT strain using 
their adaptation carbon sources (Figure 2-2), frozen stocks of each isolated strain were streaked on 
TSB plates and a single colony was grown in 2 mL of minimal medium A supplemented with 
lignin model compounds from their adaptation condition (concentrations as indicated in Table 2-
S13) for 24–48 h, and then subcultured using an initial OD600 of 0.05 in 10 mL of lignin model 
compounds from their adaptation condition (concentrations as indicated in Table 2-S14) for 24 h. 
Next, cells were centrifuged at 3000 g for 10 min and resuspended in minimal medium A without 
carbon or nitrogen sources, and experiments were performed at 30 °C with a 10 mL culture volume 
in a 50 mL glass culture tube with adaptation carbon source(s) (concentrations as indicated in 




absorbance at 600 nm (Abs600). Absorbance measurements were made with black 96 well plates 
(Greiner BioOne) using a TECAN Infinite M200 Pro plate reader. OD600 values were obtained by 
converting the Abs600 of 200μL of cell culture to OD600 using an experimentally determined 
correlation curve (OD600=1.975 * [Abs600−0.04], R
2= 1.00). Specific growth rates were calculated 
by fitting at least four converted OD600 values in the log phase. 
2.5.3 R. opacus cultures for targeted metabolomics and transcriptomics 
 
For phenotyping of adapted strains outside of adaptation conditions (Figures 2-4A, C), 
targeted metabolomics experiments (Figure 2-4B), and transcriptomic experiments (Figures 2-5, 
2-6), cultures were started as follows. −80 °C frozen stocks of isolated colonies were streaked onto 
TSB agar plates and grown at 30 °C for three days. Using a loopful of cells from a TSB plate, seed 
cultures were grown at 30 °C in 2 mL of minimal medium A or B supplemented with lignin model 
compounds (0.2 g/L of BEN, GUA, PHE, HBA, and VAN, 1 g/L total aromatics) as carbon sources 
for 24 h, and then subcultured in 10 mL of the same media for 24 h with an initial cell density 
(OD600) of 0.05. Next, cells were centrifuged at 3000 g for 10 min and resuspended in minimal 
medium A or B without carbon or nitrogen sources, and experiments were performed at 30 °C with 
a 10 mL culture volume in a 50 mL glass culture tube with respective carbon source(s) (see below 
for concentrations) and 1 g/L ammonium sulfate as the nitrogen source. For phenotyping of strains 
outside of adaptation conditions, 0.5 g/L of BEN, GUA, PHE, HBA, and VAN (2.5 g/L total 
aromatics), 0.6 g/L of BEN, GUA, PHE, HBA, and VAN (3.0 g/L total aromatics), or a 
combination of aromatics and glucose were used as carbon sources (at concentrations as indicated 
in figure captions). For targeted metabolomics experiments, 0.5 g/L of BEN, GUA, PHE, HBA, 
and VAN (2.5 g/L total aromatics) were used as carbon sources. For growth assays using individual 




GUA (1.25, 1.5, 1.75, 2, 2.25, and 2.5 g/L), PHE (0.75, 1, 1.25, 1.5, 1.75, and 2 g/L), HBA (2, 
2.25, 2.5, 2.75, 3, and 3.25 g/L), and VAN (1.25, 1.5, 1.75, 2, 2.25, and 2.5 g/L) were used. For 
transcriptomic experiments, seven different growth media were used: 0.5 g/L of BEN, 0.5 g/L of 
GUA, 0.5 g/L of PHE, 0.5 g/L of HBA, 0.5 g/L of VAN, and 1 g/L of glucose; and 0.5 g/L of 
BEN, GUA, PHE, HBA, and VAN (2.5 g/L total aromatics). Carbon sources are listed in the 
respective figure or table. Growth was monitored using Abs600 as described previously. 
2.5.4 DNA extraction and sequencing library preparation 
 
DNA was extracted using a standard bead-beating, phenol-chloroform extraction 
methodology [86], and DNA concentrations were quantified using a Quant-iT PicoGreen dsDNA 
Assay Kit (Thermo Fisher Scientific). The DNA was prepared for sequencing using a Nextera 
Tagmentation Kit (Illumina) [122, 123]. Samples were barcoded using a KAPA HiFi HotStart 
ReadyMix PCR Kit (KAPA Biosystems). The resulting PCR products were cleaned using 
Agencourt AMPure XP Beads (Agencourt Bioscience Corporation) and stored at −20 °C until use. 
For sequencing, samples were pooled together in equimolar ratios and diluted to a final DNA 
concentration of 10 nM using nuclease free water. 
2.5.5 Genome sequencing and SNP analysis 
 
For whole genome sequencing (Figure 2-3), 20μL of the pooled barcoded DNA samples 
were submitted for sequencing at the Center for Genome Sciences & Systems Biology, 
Washington University in St. Louis School of Medicine. Samples were paired-end sequenced 
using an Illumina Hi-Seq 2500 System. Raw Illumina paired-end reads were demultiplexed using 
barcodes and quality trimmed using Trimmomatic [124]. Trimmed reads were mapped to the 




updated RefSeq annotation (GCF_000599545.1) using Bowtie2 [125]. The resulting SAM files 
were converted to BAM files and indexed using SAMtools [126]. SNPs and INDELs were called 
using Pilon [127], and SNPs also appearing in the WT strain were removed using an in-house 
Python script before quality filtering using GATK [128]. Trimmed reads were also de novo 
assembled using SPAdes [129], and the resulting genome assembly was used to confirm the 
presence or absence of SNPs using BLAST+ [130]. Additionally, de novo confirmed SNPs were 
compared to another reference genome from the Broad Institute (ASM23433v1) [131] to filter out 
SNPs that were identical to the Broad Institute reference genome. Gene Ontologies [98] were 
inferred with Blast2GO [132] by finding the top 20 most similar protein sequences in the NCBI 
and UniProt Knowledgebase databases for every protein in the R. opacus genome using BLAST+ 
and InterProScan [133]. 
2.5.6 RNA extraction and rRNA depletion 
 
RNA was extracted using a ZR Fungal/Bacterial RNA MiniPrep Kit (Zymo Research) and 
treated with TURBO DNase I (Ambion) for 30 min at 37 °C to remove DNA contamination. 
DNase-treated RNA was then cleaned using an RNA Clean & Concentrator Kit (Zymo Research). 
Samples were checked for DNA contamination by PCR amplification using primers specific to 
intergenic regions of the genome. Samples that were positive for DNA contamination were re-
treated with TURBO DNase I and cleaned until no DNA was detected by PCR amplification. Next, 
RNA was quantified using a NanoVue Plus™ Spectrophotometer (Biochrom), and ribosomal 
RNA (rRNA) was depleted from total RNA using a Bacterial Ribo-Zero rRNA Removal Kit 
(Illumina). The resulting mRNA was converted to cDNA and barcoded using a reverse 
transcription protocol described previously [86]. cDNA samples were pooled together in 




2.5.7 Transcriptomic analysis 
 
For transcriptomic analysis of WT and PVHG6 strains (Figures 2-5, 2-6), 20 μL of the 
pooled barcoded cDNA samples were submitted for sequencing at the Center for Genome Sciences 
& Systems Biology, Washington University in St. Louis School of Medicine. Samples were single-
end sequenced using an Illumina Hi-Seq 2500 System. Raw single-end reads were demultiplexed, 
trimmed, and mapped in the same manner as the SNP analysis described previously. After indexing 
mapped reads, expression counts were calculated for each gene using featureCounts [134], and 
downstream differential gene expression analysis was performed using DESeq2 [135]. 
2.5.8 Aromatic consumption profiling 
 
For cultures using a single carbon source, the concentration of each lignin model compound 
was estimated by comparing UV absorbance values to a standard curve for each lignin model 
compound (Figures 2-4C, 2-S22). 200μL of each cell culture was centrifuged at 16,000 g for 5 
min, and the UV absorbance value of a 100-fold dilution of culture supernatant was measured in a 
UV transparent 96 well plate (ThermoScientific) using a TECAN Infinite M200 Pro plate reader, 
or in a quartz cuvette using a Nanodrop 2000 (Thermo Scientific). For cultures using the aromatic 
mixture (Figure 2-4B), aromatics in the culture supernatant were derivatized using methyl 
chloroformate [136] and quantified using a custom GC-MS-FID system (gas chromatography-
mass spectrometry-flame ionization detector). Briefly, the culture supernatant was centrifuged at 
16,000 g for 5 min, and 200 μL of the culture supernatant was mixed with 40 μL of 5.0% (w/w) 
sodium hydroxide solution, 200 μL of methanol, and 50 μL of pyridine. Methylchloroformate (50 
μL) was added to the mixture in two 25 μL aliquots. Next, 400 μL of chloroform containing a 
decane internal standard was added to the sample, followed by the addition of 400 μL of 50 mM 




were vortexed between each step to ensure complete mixing. After phase separation, the organic 
phase was transferred to a GC vial with a 350 μL glass insert (Agilent), and samples were analyzed 
using an Agilent 7890A GC coupled to both an Agilent 5975C mass spectrometer containing a 
triple-axis detector and an Agilent G3461A FID detector with a methanizer (Activated Research 
Company). The Agilent 7890A GC was equipped with a Restek fused silica RTX-50 capillary 
column (30 m by 0.25 mm, 0.5 μm film thickness), and helium was used as the carrier gas. 1 μL 
of the organic phase was injected with a splitting ratio of 10:1 using the autosampler. For GC runs, 
the inlet was maintained at 250 °C, and the oven was held for 2 min at 40 °C, heated to 300 °C 
using a 5 °C/min ramp, and held at 300 °C for 5 min. All data was exported and analyzed using 
the Agilent ChemStation Software, and peak intensities were normalized to the decane internal 
standard. Lignin model compounds were identified based on retention time and mass spectral 
database searches using the Palisade Complete Mass Spectral Database (600 K edition, Palisade 
Mass Spectrometry, Ithaca, NY), and concentrations were determined using an external standard 
curve for each lignin model compound. 
2.5.9 Lipid assay 
 
For lipid production assays (Figure 2-7), growth experiments were performed in the same 
way as metabolomic and transcriptomic experiments with the following modification: the culture 
volume was 50 mL in a 250 mL baffled flask, the carbon sources for the experiment were 0.5 g/L 
of BEN, GUA, PHE, HBA, and VAN (2.5 g/L total aromatics), and the nitrogen source for the 
experiment was 0.125 g/L ammonium sulfate. Lipid was measured gravimetrically using a 
modified Folch lipid extraction [137]. To measure biomass content, 10 mL of cell culture was 
centrifuged at 4600 g for 15 min, washed twice with distilled water, dried at 60 °C for two days, 




centrifuged at 4600 g for 15 min, washed twice with distilled water, and resuspended in 4 mL of a 
chloroform/methanol solution (2:1). Next, the solution was sonicated at 20% amplitude using the 
program: 1 s on and 1 s off for 5 min. The solution was partitioned into aqueous and organic phases 
using 0.2 volumes of 0.9% NaCl solution. The organic phase was separated from the aqueous 
phase, dried under vacuum, and weighed to determine the total lipid amount. 
2.5.10 Generation of R. opacus knockout mutants 
 
Knockout mutants were generated via homologous recombination in the wild type R. 
opacus strain as described previously [138]. Briefly, a helper plasmid expressing a pair of 
recombinases (pDD120) was introduced via electroporation into WT R. opacus. Electrocompetent 
cells were made from this strain as previously described [106]. An integration vector containing 
an antibiotic resistance marker and DNA regions homologous to each target gene (~ 500 bp per 
homologous arm) was then introduced into the strain harboring the recombinase helper plasmid 
by electroporation [138]. Successful recombination was confirmed by colony PCR. See Table 2-
S15 for plasmids utilized for knockouts and Table 2-S16 for all strains generated. Plasmid DNA 
was isolated from Escherichia coli DH10B for electroporation into R. opacus using the Zyppy 
Plasmid Miniprep Kit (Zymo). 
2.5.10 Data Availability 
 
 Genomic and transcriptomic sequences have been deposited with the Sequence Read 






2.6 Supplemental Figures 
 
Figure 2-S1: Cell density comparison between WT and adapted strains. Values are based on 
the data in Figure 2-2 and reported as improvement of final cell density (OD600) in the adapted 
strain compared to OD600 of the WT strain. % improvement = (AdaptedOD600 – WTOD600) / WTOD600 
x 100%, where AdaptedOD600 and WTOD600 is the OD600 of the adapted and WT strains, 
respectively, after 43 hours of growth. Cells were grown in a minimal salts medium supplemented 
with the listed carbon sources as the sole carbon sources and 1 g/L ammonium sulfate as the 
nitrogen source. (A) The phenol adapted strains (P1-6). (B) The phenol and vanillate adapted 
strains (PV1-6). (C) The phenol, vanillate, and 4-hydroxybenzoate adapted strains (PVH1-6). (D) 
The phenol, vanillate, 4-hydroxybenzoate, and guaiacol adapted strains (PVHG1-6). (E) The 
sodium benzoate adapted strains (B1-6).  (F) The high glucose adapted strains (Glc1-6). Bars 
represent the average of three biological replicates and error bars represent one standard deviation. 
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Figure 2-S2: Aromatic concentrations in culture supernatants after 43 hours for WT and 
aromatic compound adapted strains. A. The PHE and VAN adapted strain PV1 compared to the 
WT strain using 1.2 g/L PHE and 1.2 g/L VAN. B. The PHE, VAN, and HBA adapted strain PVH5 
compared to the WT strain using 0.5 g/L PHE, 1 g/L HBA, and 1 g/L VAN. C. The PHE, VAN, 
HBA, and GUA adapted strain PVHG6 compared to the WT strain using 0.4 g/L GUA, 0.4 g/L 
PHE, 0.7 g/L HBA, and 0.7 g/L VAN. D. The sodium benzoate adapted strain B2 compared to the 
WT strain using 9.4 g/L BEN. E. The phenol adapted strain P1 compared to the WT strain using 
1.1 g/L PHE. Aromatic concentrations were measured by derivatizing culture supernatants using 
methyl chloroformate followed by GC-MS-FID (see Materials and Methods for details). Cells 
were grown in a minimal medium A supplemented with the listed carbon sources (same as Fig. 2) 
as the sole carbon sources and 1 g/L ammonium sulfate as the nitrogen source. Bars represent the 
average of three biological replicates and error bars represent one standard deviation. The dotted 
lines indicate the initial aromatic concentration. PHE = phenol, VAN = vanillate, HBA = 4-







Figure 2-S3: Genes with non-synonymous and intergenic SNPs in adapted strains separated 
by adaptation conditions. Some genes have multiple mutations, so each row represents a specific 
mutation. Strain names indicate the adaptation condition from which the strain originates: P = 
phenol; PV = phenol and vanillate; PVH = phenol, vanillate, and 4-hydroxybenzoate; PVHG = 






Figure 2-S4: Average sequencing depth for all sequenced strains (35 mutants and WT) and 
normalized counts in all transcriptomic samples (PVHG6 and WT). A. The average 
sequencing depth per base pair in the chromosome or plasmids. Average sequencing depth values 
were calculated by summing the total sequencing depth of all the individual base pairs on the 
chromosome or plasmid and dividing by the number of base pairs on the respective chromosome 
or plasmid. Sequencing depths were then normalized by the average depth of the chromosome for 
each strain. B. Average normalized counts were calculated by summing the total number of reads 
per kilobase of transcript per million mapped reads (RPKM) for each gene on the chromosome or 
plasmid and dividing by the number of genes on the respective chromosome or plasmid. The 
average RPKM values were then normalized by the average RPKM value of the chromosome for 
each strain. Glc = 1 g/L glucose, P = 0.5 g/L phenol, V = 0.5 g/L vanillate, H = 0.5 g/L 4-
hydroxbenzoate, G = 0.5 g/L guaiacol, B = 0.5 g/L sodium benzoate, and Mixture = 0.5 g/L of 
phenol, vanillate, 4-hydroxybenzoate, guaiacol, and sodium benzoate (2.5 g/L total aromatics). For 
Glc and Mixture, “1” represents cells harvested at early exponential phase (10 hours for Glc; 20 
hours for Mixture), while “2” represents cells harvested at mid-exponential phase (13 hours for 
Glc; 32 hours for Mixture). Samples from individual compound growth conditions were harvested 
at mid-exponential phase (24 hours for WT P, 21 hours for PVHG6 P, 19 hours for WT and 
PVHG6 G, 11 hours for WT and PVHG6 H, 12 hours for WT and PVHG6 B, and 24 hours for 
WT and PVHG6 V). All transcriptomics experiments were performed in minimal medium A. For 





Figure 2-S5: Comparison of superoxide dismutase (SOD) activity from WT and PVHG6 cell 
lysates. Measured relative SOD activity from WT and PVHG6 cell lysates. Asterisk indicates 
significant difference from WT SOD activity (P = 0.002, one mean, two-tailed Student’s t-test). 
Cells were initially cultured in 2 mL of minimal medium A supplemented with 0.2 g/L of sodium 
benzoate, phenol, guaiacol, 4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 1 g/L 
ammonium sulfate for 24 hours, and then subcultured in 10 mL of minimal medium A 
supplemented with 0.2 g/L of sodium benzoate, phenol, guaiacol, 4-hydroxybenzoate, and 
vanillate (1 g/L total aromatics) and 1 g/L ammonium sulfate for 24 hours to an OD600 of ~0.5. 
Cells were grown in 100 mL of minimal medium A supplemented with 1 g/L glucose and 1 g/L 
ammonium sulfate to mid-exponential phase (OD600 = 0.44-0.49 for both strains; three replicates). 
Cultures (the same number of cells equivalent to OD600 = 0.44 for both strains by adjusting 
volumes for harvesting) were centrifuged at 1000g and 4 °C for 15 minutes, resuspended in 300 
µL of EMD Millipore BugBuster Protein Extraction Reagent, and incubated at room temperature 
for 30 minutes. Next, the lysed cells were centrifuged at 16,000g and 4 °C for 10 minutes, and a 
ten-fold dilution of supernatant was used for testing. SOD activity was measured using the 
Invitrogen Superoxide Dismutase Colorimetric Activity Kit. SOD activity was compared to a 
standard curve generated using bovine erythrocyte superoxide dismutase in the Kit. Bars represent 






























Figure 2-S6: Growth of WT and adapted strains in a mixture of lignin model compounds. 
Growth of strains isolated from adapted cultures in 0.6 g/L of sodium benzoate, phenol, guaiacol, 
4-hydroxybenzoate, and vanillate (3 g/L total aromatics) using minimal medium A. Cells were 
initially cultured in 2 mL of minimal medium A supplemented with 0.2 g/L of sodium benzoate, 
phenol, guaiacol, 4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 1 g/L ammonium 
sulfate for 24 hours, and then subcultured in 10 mL of minimal medium A supplemented with 0.2 
g/L of sodium benzoate, phenol, guaiacol, 4-hydroxybenzoate, and vanillate (1 g/L total aromatics) 
and 1 g/L ammonium sulfate for 24 hours to an OD600 of ~0.5. For all data shown, cultures were 
grown in 10 mL of minimal medium A supplemented with 1 g/L ammonium sulfate as the nitrogen 
source with an initial OD600 of 0.05. Points represent the average of three biological replicates and 































Figure 2-S7: Growth of PVHG6 using glucose, lignin model compounds, and a mixture of 
glucose and lignin model compounds as carbon sources. Growth of PVHG6 in 0.6 g/L each of 
sodium benzoate, phenol, guaiacol, 4-hydroxybenzoate, and vanillate (3 g/L total aromatics), 3 g/L 
glucose (glc), or both glucose and aromatics as carbon sources. Cells were initially cultured in 2 
mL of minimal medium B supplemented with 0.2 g/L each of sodium benzoate, phenol, guaiacol, 
4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 1 g/L ammonium sulfate for 24 hours, 
and then subcultured in 10 mL of minimal medium B supplemented with 0.2 g/L each of sodium 
benzoate, phenol, guaiacol, 4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 1 g/L 
ammonium sulfate for 24 hours to an OD600 of ~0.5. For all data shown, cultures were grown in 
10 mL of minimal medium B supplemented with 1 g/L ammonium sulfate as the nitrogen source 
with an initial OD600 of 0.1. Points represent the average of three biological replicates and error 
bars represent one standard deviation. Asterisk (*) indicates a significantly higher OD600 value (P 
< 0.05, one mean, two-tailed Student’s t-test) for the 3 g/L glucose + 3 g/L aromatics condition 
than both the 3 g/L glucose and 3 g/L aromatics conditions. Analysis of derivatized culture 
supernatants by GC-MS-FID at the 60 hour time point showed that all aromatics were consumed 






Figure 2-S8: Growth comparison of PVHG6 and WT strains using individual lignin model 
compounds. Growth comparison of PVHG6 and WT strains in different concentrations of 
individual lignin model compounds. The individual compound used for growth is listed next to the 
y-axis, and the strain is listed above each column. Cells were initially cultured in 2 mL of minimal 
medium A supplemented with 0.2 g/L of sodium benzoate, phenol, guaiacol, 4-hydroxybenzoate, 
and vanillate (1 g/L total aromatics) and 1 g/L ammonium sulfate for 24 hours, and then 
subcultured in 10 mL of minimal medium A supplemented with 0.2 g/L of sodium benzoate, 
phenol, guaiacol, 4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 1 g/L ammonium 
sulfate for 24 hours to an OD600 of ~0.5.  For all data shown, cultures were grown in 10 mL of 
minimal medium A supplemented with 1 g/L ammonium sulfate as the nitrogen source with an 
initial OD600 of 0.05. Points represent the average of three biological replicates and error bars 
represent one standard deviation. PHE = phenol, GUA = guaiacol, VAN = vanillate, HBA = 4-


































































































































































































































Figure 2-S9: Phenol (PHE) consumption profiles of WT and PVHG6 strains grown in 
different PHE concentrations. A. 0.75 g/L. B. 1 g/L. C. 1.25 g/L. D. 1.5 g/L. E. 1.75 g/L. F. 2 
g/L. Points represent the average of three biological replicates and error bars represent one standard 
deviation. Phenol concentration was measured in culture supernatants using absorbance at 270 nm. 














































































Figure 2-S10: Guaiacol (GUA) consumption profiles of WT and PVHG6 strains grown in 
different GUA concentrations. A. 1.25 g/L. B. 1.5 g/L. C. 1.75 g/L. D. 2 g/L. E. 2.25 g/L. F. 2.5 
g/L. Points represent the average of three biological replicates and error bars represent one standard 
deviation. Guaiacol concentration was measured in culture supernatants using absorbance at 274 



















































































Figure 2-S11: Sodium benzoate (BEN) consumption profiles of WT and PVHG6 strains 
grown in different BEN concentrations. A. 5 g/L. B. 6 g/L. C. 7 g/L. D. 8 g/L. E. 9 g/L. F. 10 
g/L BEN. Points represent the average of three biological replicates and error bars represent one 
standard deviation. Sodium benzoate concentration was measured in culture supernatants using 







































































Figure 2-S12: Vanillate (VAN) consumption profiles of WT and PVHG6 strains grown in 
different VAN concentrations. A. 1.25 g/L. B. 1.5 g/L. C. 1.75 g/L. D. 2 g/L. E. 2.25 g/L. F. 2.5 
g/L. Points represent the average of three biological replicates and error bars represent one standard 
deviation. Vanillate concentration was measured in culture supernatants using absorbance at 284 













































































Figure 2-S13: 4-hydroxybenzoate (HBA) consumption profiles of WT and PVHG6 strains 
grown in different HBA concentrations. A. 2 g/L. B. 2.25 g/L. C. 2.5 g/L. D. 2.75 g/L. E. 3 g/L. 
F. 3.25 g/L. Points represent the average of three biological replicates and error bars represent one 
standard deviation. 4-hydroxybenzoate concentration was measured in culture supernatants using 







































































Figure 2-S14: Growth of WT and PVHG6 strains on 1 g/L glucose. Cells were initially cultured 
in 2 mL of minimal medium A supplemented with 0.2 g/L of sodium benzoate, phenol, guaiacol, 
4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 1 g/L ammonium sulfate for 24 hours, 
and then subcultured into 10 mL of the same media for 24 hours to an OD600 of ~0.5. Cultures 
were grown in 10 mL of minimal medium A supplemented with 1 g/L glucose as the carbon source 
and 1 g/L ammonium sulfate as the nitrogen source with an initial OD600 of 0.05. Points represent 







Figure 2-S15: Principal component analysis of all WT and PVHG6 transcriptomes. Principal 
component analysis was done using normalized counts of all genes in R. opacus. Glc = 1 g/L 
glucose, Multi = 0.5 g/L of PHE, VAN, HBA, GUA, and BEN (2.5 g/L total aromatics). Other 
compounds listed in legend were used at a concentration of 0.5 g/L. For Glc and Multi, t1 represents 
cells harvested at early exponential phase (10 hours for Glc; 20 hours for Multi), while t2 represents 
cells harvested at mid-exponential phase (13 hours for Glc, 32 hours for Multi). Samples from 
individual compound growth conditions were harvested at mid-exponential phase (24 hours for 
WT PHE and 21 hours for PVHG6 PHE; 19 hours for WT and PVHG6 GUA; 11 hours for WT 
and PVHG6 HBA; 12 hours for WT and PVHG6 BEN; 24 hours for WT and PVHG6 VAN). All 
transcriptomics experiments were performed in minimal medium A. Each symbol represents a 
biological replicate. Analysis was performed with normalized counts using the variance stabilizing 
transformation from the DESeq2 software package. PC1 = 1st principal component and PC2 = 2nd 
principal component. PHE = phenol, VAN = vanillate, HBA = 4-hydroxybenzoate, GUA = 





Figure 2-S16: Principal component analysis of all WT and PVHG6 transcriptomes with 
Plasmids 1 and 2 removed. Principal component analysis was done using normalized counts of 
all genes in R. opacus except those located on Plasmids 1 and 2. Glc = 1 g/L glucose, Multi = 0.5 
g/L of PHE, VAN, HBA, GUA, and BEN (2.5 g/L total aromatics). Other compounds listed in 
legend were used at a concentration of 0.5 g/L. For Glc and Multi, t1 represents cells harvested at 
early exponential phase (10 hours for Glc; 20 hours for Multi), while t2 represents cells harvested 
at mid-exponential phase (13 hours for Glc, 32 hours for Multi). Samples from individual 
compound growth conditions were harvested at mid-exponential phase (24 hours for WT PHE and 
21 hours for PVHG6 PHE; 19 hours for WT and PVHG6 GUA; 11 hours for WT and PVHG6 
HBA; 12 hours for WT and PVHG6 BEN; 24 hours for WT and PVHG6 VAN). All 
transcriptomics experiments were performed in minimal medium A. Each symbol represents a 
biological replicate. Analysis was performed with normalized counts using the variance stabilizing 
transformation from the DESeq2 software package. PC1 = 1st principal component and PC2 = 2nd 
principal component. PHE = phenol, VAN = vanillate, HBA = 4-hydroxybenzoate, GUA = 






Figure 2-S17: Expression of the top 30 most upregulated genes in PVHG6 compared to the 
WT strain in the mixture of lignin model compounds. Glc = 1 g/L glucose, PHE = 0.5 g/L 
phenol, VAN = 0.5 g/L vanillate, HBA = 0.5 g/L 4-hydroxbenzoate, GUA = 0.5 g/L guaiacol, 
BEN = 0.5 g/L sodium benzoate, and Multi = 0.5 g/L of phenol, vanillate, 4-hydroxybenzoate, 
guaiacol, and sodium benzoate (2.5 g/L total aromatics). t1 represents cells harvested at early 
exponential phase (10 hours for Glc; 20 hours for Multi), while t2 represents cells harvested at mid-
exponential phase (13 hours for Glc; 32 hours for Multi). Samples from individual compound 
growth conditions were harvested at mid-exponential phase (24 hours for WT PHE, 21 hours for 
PVHG6 PHE, 19 hours for WT and PVHG6 GUA, 11 hours for WT and PVHG6 HBA, 12 hours 
for WT and PVHG6 BEN, and 24 hours for WT and PVHG6 VAN). All transcriptomics 
experiments were performed in minimal medium A. Raw counts were transformed using the 
variance stabilizing transformation in DESeq2. Darker colors indicate higher normalized counts 














































































RS13410 Type VII secretion-associated protein
RS27075 Hypothetical protein
RS13405 Type VII secretion protein EccC
RS25970 Galactonate dehydratase
RS20280 ABC transporter ATP binding protein
RS20285 ABC transporter
RS41175 ATP binding protein
RS20480 ATP binding protein
RS17305 ATP binding protein
RS17985 GGDEF domain-containing protein (pseudogene)
RS34200 ATP binding protein




RS34100 MaoC family dehydratase
RS00690 ABC transporter substrate binding protein




RS13400 Type VII secretion integral membrane protein
RS33995 CoA transferase
RS34000 Enoyl-CoA hydratase
RS43025 Hypothetical protein (pseudogene)
RS34110 Acyl-CoA dehydrogenase
RS34265 Hypothetical protein







Figure 2-S18: Growth of transporter knockout mutants compared to that of the WT strain 
using aromatic carbon sources. Cells were initially cultured in 2 mL of minimal medium A 
supplemented with 0.2 g/L of sodium benzoate, phenol, guaiacol, 4-hydroxybenzoate, and 
vanillate (1 g/L total aromatics) and 1 g/L ammonium sulfate for 24 hours, and then subcultured 
into 10 mL of the same media for 24 hours to an OD600 of ~0.5. For all data shown, cultures were 
grown in 10 mL of minimal medium A supplemented with 1 g/L ammonium sulfate as the 
nitrogen source and the carbon source as indicated in the figure with an initial OD600 of 0.05. 
Bars represent the average of three biological replicates and error bars represent one standard 
deviation. PHE = phenol, VAN = vanillate, HBA = 4-hydroxybenzoate, GUA = guaiacol, BEN = 
sodium benzoate, and Mix = 0.5 g/L of PHE, VAN, HBA, GUA and BEN (2.5 g/L total 
aromatics). ∆ShikiT = RS31355 knockout mutant, ∆BenT = RS30810 knockout mutant, and 






Figure 2-S19: Putative C1 metabolism during growth on vanillate and guaiacol. Heat map of 
normalized gene expression counts for genes putatively involved in C1 metabolism. Glc = 1 g/L 
glucose, PHE = 0.5 g/L phenol, VAN = 0.5 g/L vanillate, HBA = 0.5 g/L 4-hydroxbenzoate, GUA 
= 0.5 g/L guaiacol, BEN = 0.5 g/L sodium benzoate, and Multi = 0.5 g/L of phenol, vanillate, 4-
hydroxybenzoate, guaiacol, and sodium benzoate (2.5 g/L total aromatics). t1 represents cells 
harvested at early exponential phase (10 hours for Glc; 20 hours for Multi), while t2 represents 
cells harvested at mid-exponential phase (13 hours for Glc; 32 hours for Multi). Samples from 
individual compound growth conditions were harvested at mid-exponential phase (24 hours for 
WT PHE, 21 hours for PVHG6 PHE, 19 hours for WT and PVHG6 GUA, 11 hours for WT and 
PVHG6 HBA, 12 hours for WT and PVHG6 BEN, and 24 hours for WT and PVHG6 VAN). All 
transcriptomics experiments were performed in minimal medium A. Raw counts were transformed 
using the variance stabilizing transformation in DESeq2. Darker colors indicate higher normalized 








































































RS21450 LuxR transcriptional regulator 
RS21455 3-hexulose-6-phosphate isomerase
RS21460 3-hexulose-6-phosphate synthase






RS21495 AraC family transcriptional regulator
RS21500 Glucose-6-phosphate dehydrogenase
RS21505 6-phosphogluconate dehydrogenase


















Figure 2-S20: Expression of genes with SNPs in PVHG6. Heat map of normalized gene 
expression counts for genes with SNPs in PVHG6. Glc = 1 g/L glucose, PHE = 0.5 g/L phenol, 
VAN = 0.5 g/L vanillate, HBA = 0.5 g/L 4-hydroxbenzoate, GUA = 0.5 g/L guaiacol, BEN = 0.5 
g/L sodium benzoate, and Multi = 0.5 g/L of phenol, vanillate, 4-hydroxybenzoate, guaiacol, and 
sodium benzoate (2.5 g/L total aromatics). t1 represents cells harvested at early exponential phase 
(10 hours for Glc; 20 hours for Multi), while t2 represents cells harvested at mid-exponential phase 
(13 hours for Glc; 32 hours for Multi). Samples from individual compound growth conditions were 
harvested at mid-exponential phase (24 hours for WT PHE, 21 hours for PVHG6 PHE, 19 hours 
for WT and PVHG6 GUA, 11 hours for WT and PVHG6 HBA, 12 hours for WT and PVHG6 
BEN, and 24 hours for WT and PVHG6 VAN). All transcriptomics experiments were performed 
in minimal medium A. Raw counts were transformed using the variance stabilizing transformation 
in DESeq2. Darker colors indicate higher normalized counts (see scale bar). Gene codes are from 


































































RS02790 Hypothetical protein 
RS11630 Acyl-CoA dehydrogenase
RS13070 Non-ribosomal peptide synthetase
RS14345 DeoR family transcriptional regulator
RS14470 Aspartate aminotransferase













RS37840 Serine/threonine protein kinase
RS41665 Succinate semialdehyde dehydrogenase


















Figure 2-S21: Expression of genes with SNPs in PVHG6. Heat map of normalized gene 
expression counts for genes with SNPs in PVHG6. Glc = 1 g/L glucose, PHE = 0.5 g/L phenol, 
VAN = 0.5 g/L vanillate, HBA = 0.5 g/L 4-hydroxbenzoate, GUA = 0.5 g/L guaiacol, BEN = 0.5 
g/L sodium benzoate, and Multi = 0.5 g/L of phenol, vanillate, 4-hydroxybenzoate, guaiacol, and 
sodium benzoate (2.5 g/L total aromatics). t1 represents cells harvested at early exponential phase 
(10 hours for Glc; 20 hours for Multi), while t2 represents cells harvested at mid-exponential phase 
(13 hours for Glc; 32 hours for Multi). Samples from individual compound growth conditions were 
harvested at mid-exponential phase (24 hours for WT PHE, 21 hours for PVHG6 PHE, 19 hours 
for WT and PVHG6 GUA, 11 hours for WT and PVHG6 HBA, 12 hours for WT and PVHG6 
BEN, and 24 hours for WT and PVHG6 VAN). All transcriptomics experiments were performed 
in minimal medium A. Raw counts were transformed using the variance stabilizing transformation 
in DESeq2. Darker colors indicate higher normalized counts (see scale bar). Gene codes are from 



































































RS10095 Fructose bisphosphate aldolase
RS14825 Cytochrome ubiquinol oxidase subunit I
RS21245 Non-ribosomal peptide synthease
RS32480 Phosphotransferase








RS37840 Serine/threonine protein kinase
RS42725 Hypothetical protein
RS38565 Succinate semialdehyde dehydrogenase
RS41665 Succinate semialdehyde dehydrogenase
RS38570 Oxidoreductase


















Figure 2-S22: Calibration curves for estimation of lignin model compound concentrations. 
Wavelength used for each calibration curve is listed on the x-axis of each plot, and the fitted 
correlation equation used to calculate concentrations are listed in each plot. A. Guaiacol calibration 
curve. B. Phenol calibration curve. C. 4-hydroxybenzoate calibration curve. D. Vanillate 
calibration curve. E. Sodium benzoate calibration curve. For A-D, measurements were performed 
by diluting 5 g/L stock solutions prepared in minimal medium A with no carbon or nitrogen sources 
and then measuring absorbance using a TECAN Infinite M200 Pro plate reader in a UV transparent 
96 well plate. For E, dilutions were performed in the same way, but absorbance was measured 
using a Nanodrop 2000 with a quartz cuvette. See Materials and Methods for more information 
about measurement of lignin model compounds. PHE = phenol, GUA = guaiacol, VAN = vanillate, 
HBA = 4-hydroxybenzoate, BEN = sodium benzoate.  
 
















































































Table 2-S1: Adaptive evolution summary. Concentrations listed are final concentrations from 
adaptation. PCA = protocatechuate, GUA = guaiacol, PHE = phenol, HBA = 4-hydroxybenzoate, 
VAN = vanillate, BEN = sodium benzoate, and GLC = glucose. * No.: 3 = P, 14 = PV, 25 = PVH, 






















1 40 4.58 - - - - - - 4.58 
2 83 - 1.67 - - - - - 1.67 
3 80 - - 1.50 - - - - 1.50 
4 60 - - - 3.09 - - - 3.09 
5 48 - - - - 2.06 - - 2.06 
6 56 2.85 0.47 - - - - - 3.32 
7 63 3.32 - 0.55 - - - - 3.87 
8 60 2.63 - - 0.88 - - - 3.51 
9 62 3.24 - - - 1.08 - - 4.32 
10 62 - 0.64 0.64 - - - - 1.27 
11 42 - 0.30 - 1.06 - - - 1.36 
12 59 - 1.10 - - 1.10 - - 2.19 
13 58 - - 1.05 1.05 - - - 2.09 
14 71 - - 1.16 - 1.16 - - 2.32 
15 56 - - - 1.41 1.41 - - 2.82 
16 64 1.34 0.22 0.22 - - - - 1.78 
17 64 2.91 0.48 - 0.48 - - - 3.88 
18 74 3.18 0.53 - - 0.53 - - 4.25 
19 60 2.14 - 0.36 0.36 - - - 2.86 
20 74 3.19 - 0.53 - 0.53 - - 4.25 
21 74 2.26 - - 0.75 0.38 - - 3.39 
22 101 - 0.59 0.59 1.19 - - - 2.37 
23 70 - 0.34 0.34 - 0.69 - - 1.37 
24 79 - 0.66 - 1.33 1.33 - - 3.32 
25 67 - - 0.49 0.98 0.98 - - 2.44 
26 54 1.36 0.23 0.23 0.45 - - - 2.26 
27 104 - 0.49 0.49 0.98 0.98 - - 2.95 
28 50 1.54 - 0.26 0.51 0.51 - - 2.82 
29 42 2.99 0.50 0.50 - 1.00 - - 4.98 
30 57 1.52 0.25 - 0.51 0.51 - - 2.78 
31 60 1.51 0.25 0.25 0.50 0.50 - - 3.02 
32 72 - - - - - - 419.0 0 





Table 2-S2: Summary of comparative genomics of adapted strains. SNPs = single nucleotide 
polymorphisms; INDELs = insertions or deletions.  
 
Sample 








# of Silent 
SNPs 






P1 42 13 3 26 1 No Yes 
P2 45 16 3 26 1 No Yes 
P3 51 20 3 28 1 No Yes 
P4 46 15 3 28 1 No Yes 
P5 44 13 4 27 1 No Yes 
P6 50 16 4 30 1 No Yes 
PV1 29 9 1 19 0 No Yes 
PV2 29 9 1 19 1 No Yes 
PV3 36 9 3 24 0 No Yes 
PV4 28 8 1 19 0 No Yes 
PV5 30 10 1 19 0 No Yes 
PV6 34 11 2 21 1 No Yes 
PVH1 43 17 2 24 1 No Yes 
PVH2 36 14 2 20 1 No Yes 
PVH3 44 18 2 24 2 No Yes 
PVH5 45 19 2 24 2 No Yes 
PVH6 33 15 1 17 1 No Yes 
PVHG1 28 16 2 10 1 Yes Yes 
PVHG2 28 17 2 9 1 Yes Yes 
PVHG3 45 19 4 22 1 Yes Yes 
PVHG4 26 16 1 9 1 Yes Yes 
PVHG5 43 17 2 24 1 Yes Yes 
PVHG6 45 19 2 24 1 Yes Yes 
B1 3 2 0 1 0 No Yes 
B2 21 13 1 7 0 No No 
B3 10 6 2 2 0 No No 
B4 14 6 2 6 0 No No 
B5 46 20 3 23 0 Yes Yes 
B6 18 13 2 3 0 No No 
Glc1 30 17 2 11 0 Yes No 
Glc2 8 5 1 2 0 No No 
Glc3 28 14 3 11 0 Yes No 
Glc4 27 13 2 12 0 Yes No 
Glc5 7 4 1 2 0 No No 






Table 2-S3: INDELs in adapted strains. INDELs were identified using Pilon variant calling, 
filtered with GATK, and verified with de novo assembly of the sequenced reads using SPAdes. 
Putative annotations are from NCBI reference sequence NC_CP003949.1. See Materials and 
Methods for more information. “All” indicates all sequenced strains isolated from the indicated 
adaptation condition. Strain names indicate adaptation condition from which the strain originated: 
P = phenol adaptation condition, PV = phenol and vanillate adaptation condition, PVH = phenol, 
vanillate, and 4-hydroxybenzoate adaptation condition, and PVHG = phenol, vanillate, 4-
hydroxybenzoate, and guaiacol adaptation condition. Base Mean Expression is the average of the 
normalized counts from WT and PVHG6 transcriptomic data from all growth conditions. 
 
Strains Gene ID Annotation Type Location 
Base Mean 
Expression 
All PVHG, All PVH RS03610 
penicillin binding 
protein 
Insertion (1 bp) Chromosome 8,100 
PV2 RS18950 hypothetical protein Insertion (5 bp) Chromosome 334 




Insertion (1 bp) Chromosome 753 





Table 2-S4:  Shared SNPs between strains isolated from the same adaptation condition. 
Genes with non-synonymous and intergenic SNPs that are shared between strains isolated from 
the same adaptation condition are shown. For intergenic SNPs, the nearest gene in each direction 




Gene ID Annotation 
P RS01890/RS41735 superoxide dismutase/hypothetical protein 
 RS14825 cytochrome ubiquinol oxidase subunit I 
 RS21470 hypothetical protein 
 RS37785/RS37790 SDR family mycofactocin-dependent oxidoreductase/hypothetical protein 
 RS37790 hypothetical protein 
 RS37795 hypothetical protein 
 RS37805 amino acid permease 
 RS37810 3-oxoacyl-ACP reductase 
 RS37810/RS37815 3-oxoacyl-ACP reductase/LLM class flavin-dependent oxidoreductase 
 RS37870 exoribonuclease II 
PV RS01890 superoxide dismutase 
 RS10095 class II fructose-bisphosphate aldolase 
 RS14825 cytochrome ubiquinol oxidase subunit I 
 RS42075 hypothetical protein (pseudogene) 
 RS37805 amino acid permease 
 RS37810 3-oxoacyl-ACP reductase 
 RS37810/RS37815 3-oxoacyl-ACP reductase/LLM class flavin-dependent oxidoreductase 
PVH RS00415 AMP-dependent synthetase 
 RS02720 membrane protein 
 RS02835 ammonia channel protein 
 RS08140 phosphoenolpyruvate carboxykinase 
 RS11540 4-hydroxy-2-oxovalerate aldolase 
 RS14825 cytochrome ubiquinol oxidase subunit I 
 RS25200 L-ectoine synthase 
 RS27825 alpha/beta hydrolase 
 RS37805 amino acid permease 
 RS37810 3-oxoacyl-ACP reductase 
 RS37810/RS37815 3-oxoacyl-ACP reductase/LLM class flavin-dependent oxidoreductase 
PVHG RS01890 superoxide dismutase 
 RS11630 acyl-CoA dehydrogenase 
 RS13070 non-ribosomal peptide synthetase 
 RS14825 cytochrome ubiquinol oxidase subunit I 
 RS22580 MFS transporter 
 RS32480 phosphotransferase 
 RS35615 peptidase 
 RS37785/RS37790 SDR family mycofactocin-dependent oxidoreductase/hypotheical protein 
 RS37790 hypothetical protein 
 RS39015 serine/threonine-protein kinase PknK 
B RS03790 cold-shock protein 
 RS08140 phosphoenolpyruvate carboxykinase 




 RS15825 LysR family transcriptional regulator 





Table 2-S5: Genes with non-synonymous SNPs or intergenic SNPs found across multiple 
adaptation experiments (including the glucose adaptation experiment). For intergenic SNPs, 
the nearest gene in each direction is listed. Some genes have more than one shared SNP. Putative 
annotations are from NCBI reference sequence NZ_CP003949.1. “All” indicates that all 
sequenced strains isolated from the indicated adaptation condition contain either non-synonymous 
SNPs or intergenic SNPs that could affect gene expression. Base Mean Expression is the average 








All P, All PV, PVH6, All PVHG RS01890 superoxide dismutase Chromosome 32,010 
All B, All PVH RS08140 phosphoenolpyruvate carboxykinase Chromosome 30,198 
P2, P3, P6, All PV RS10095 class II fructose-bisphosphate aldolase Chromosome 5,291 
All P, All PV, All PVH, All PVHG RS14825 cytochrome ubiquinol oxidase subunit I Chromosome 23,629 
PV5, B2, Glc6 RS21245 non-ribosomal peptide synthetase Chromosome 110 
PV3, All PVHG RS32480 phosphotransferase Chromosome 285 





Plasmid 1 8/103 
All P, PVH3, All PVHG, B5, Glc1, 
Glc3, Glc4, Glc6 
RS37790 hypothetical protein Plasmid 1 103 
All P, B5, Glc1, Glc3, Glc4, Glc6 RS37795 hypothetical protein Plasmid 1 17 
All P, All PV, All PVH, PVHG3, 
PVHG5, PVHG6, B4, B5, Glc1, Glc3, 
Glc4, Glc6 
RS37805 amino acid permease Plasmid 1 278 
All P, All PV, All PVH, PVHG3, 
PVHG5, PVHG6, B5, Glc1, Glc3, 
Glc4, Glc6 
RS37810 3-oxoacyl-ACP reductase Plasmid 1 26 
All P, All PV, All PVH, PVHG3, 






Plasmid 1 26/374 
P2, P3, P4, P5,P6, PVHG2,PVHG4, 




Plasmid 1 24 
P1, P2, P3, P4, P6, PV6, PVHG2, 
PVHG4, PVHG5, PVHG6, B3, B4, B5, 




Plasmid 1 6 
P5, PV3, PVH3, PVH5, B6 RS38570 FAD-binding oxidoreductase (pseudogene) Plasmid 1 60 





Table 2-S6: Phyre2 results for cytochrome ubiquinol oxidase I (RS14825). The native protein 
was modeled using the Protein Homology/analogY Recognition Engine 
(www.sbg.bio.ic.ac.uk/~phyre2/). 96% of residues were modeled at >90% confidence using the 
template protein 2YEV. Mutational sensitivity is defined as the likelihood of an amino acid change 











Located in  
binding pocket? 
All P, All PVHG G to A A272 to T 6 Transmembrane helix Yes 
All PV T to C I309 to T 5 Transmembrane helix No 
All PVH T to G F366 to V 8 Transmembrane helix No 
 
Table 2-S7: Phyre2 results for superoxide dismutase (RS01890). The native protein was 
modeled using the Protein Homology/analogY Recognition Engine 
(www.sbg.bio.ic.ac.uk/~phyre2/). 96% of residues were modeled at >90% confidence using the 
template protein 1GN4. Mutational sensitivity is defined as the likelihood of an amino acid change 












All P C to T 
None, in 
regulatory region 
Not applicable Not applicable Not applicable 
All PV A to C V191 to G 8 Alpha helix No 
PVH6 A to G V37 to G 7 Alpha helix No 
All PVHG T to C Y11 to C 8 None predicted No 
 
Table 2-S8: Growth characteristics of the WT and adapted strains using a mixture of lignin 
model compounds as carbon sources (2.5 g/L total aromatics). Growth experiments were 
performed in minimal medium A. Growth rates were calculated using at least four time points in 
the log phase. Statistical significance was determined with a threshold of P < 0.05 using a one 
mean, two-tailed Student’s t-test. Growth rate and OD600 values are shown as the average of three 
biological replicates ± one standard deviation. 
 







OD600 after 70 hr 
significantly higher than 
WT? 
Max OD600 significantly 
higher than WT? 
WT 0.073 ± 0.001 0.54 ± 0.01 0.61 ± 0.01 not applicable not applicable not applicable 
P1 0.084 ± 0.002 0.78 ± 0.02 0.81 ± 0.01 yes, P = 5.3 x 10-4 yes, P = 2.1 x 10-5 yes, P = 2.2 x 10-5 
PV1 0.079 ± 0.002 0.82 ± 0.15 1.07 ± 0.13 yes, P = 0.0033 yes, P = 0.030 yes, P = 0.0034 
PVH5 0.088 ± 0.001 0.55 ± 0.03 0.55 ± 0.03 yes, P = 7.2 x 10-5 no, P = 0.77 no, P = 0.053 
PVHG6 0.088 ± 0.001 1.08 ± 0.02 1.08 ± 0.02 yes, P = 2.6 x 10-6 yes, P = 3.8 x 10-6 yes, P = 5.1 x 10-6 






Table 2-S9: Growth characteristics of the WT and adapted strains using a mixture of lignin 
model compounds as carbon sources (3.0 g/L total aromatics). Growth experiments were 
performed in minimal medium A. Growth rates were calculated using at least four time points in 
the log phase. Statistical significance was determined with a threshold of P < 0.05 using a one 
mean, two-tailed Student’s t-test. Growth rate and OD600 values are shown as the average of three 












WT 0.059 ± 0.004 0.42 ± 0.02 not applicable not applicable 
P1 0.075 ± 0.001 0.73 ± 0.01 yes, P = 0.004 yes, P = 3.8 x 10-6 
PV1 0.072 ± 0.004 0.74 ± 0.17 yes, P = 0.016 yes, P = 0.029 
PVH5 0.073 ± 0.005 0.44 ± 0.04 yes, P = 0.021 no, P = 0.38 
PVHG6 0.079 ± 0.001 0.77 ± 0.08 yes, P = 0.001 yes, P = 0.001 
B2 0.077 ± 0.005 0.41 ± 0.04 yes, P = 0.011 no, P = 0.78 
 
Table 2-S10: Half maximal inhibitory concentration (IC50) of individual lignin model 
compounds for WT and PVHG6 strains. Growth experiments were performed in minimal 
medium A. IC50 values were calculated using Prism (GraphPad Software, Inc.) with a four-
parameter inhibitor response curve from OD600 measurements after 54 hours of growth. Statistical 
significance was determined with a threshold of P < 0.05 using a one mean, two-tailed Student’s 







PVHG6 vs. WT 
difference (%) 
PVHG6 significantly different 
from WT? 
Phenol 1.07 ± 0.05 1.25 ± 0.01 17 yes, P = 0.003 
Vanillate 2.12 ± 0.03 2.00 ± 0.05 -6 yes, P = 0.025 
4-hydroxybenzoate 2.71 ± 0.02 2.73 ± 0.01 1 no, P = 0.157 
Guaiacol 1.64 ± 0.04 1.90 ± 0.03 16 yes, P = 0.008 
Sodium benzoate 7.41 ± 0.31 6.87 ± 0.16 -7 no, P = 0.055 
 
Table 2-S11: Data from genome sequencing and RNA-Seq performed in this study. See the 
supplementary file at https://www.sciencedirect.com/science/article/pii/S1096717618300910  for 
Tables.  
 
Tab 1: All SNPs in adapted strains organized by strain. 
Tab 2: All SNPs in adapted strains organized by genome order. 
Tab 3: All INDELs in adapted strains. 
Tab 4: Summary of transcriptomic data for genes with mutations, β-ketoadipate pathway 
genes, funneling pathway genes, aromatic transporter genes, and C1 metabolism genes.   





Table 2-S12: Homology of RS34105 and RS34095 (upregulated in PVHG6 compared to WT) 
to putative 3-oxoadipyl-CoA thiolases. R. opacus PD630 proteins were compared to the R. 
opacus PD630 proteome and the R. jostii RHA1 proteome using NCBI blastp 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi). The E value represents the number of hits expected by 
random chance when searching the database (the smaller value, the more significant match). The 
amino acid positive percent identity between each protein pair is reported as the number of 
identical or physically similar amino acids. If the protein has been characterized and named, the 
name is listed under notes.  
 
R. opacus Gene code Gene code 
Amino Acid Positive  
% Identity 
E value Notes 
Pd630_RS34105 RHA1_ro02517 306/403 (75%) 0 CatF 
 RHA1_ro01340 309/406 (76%) 0 PcaF 
 RHA1_ro02863 220/417 (52%) 5e-81 PaaE 
 Pd630_RS31575 303/401 (75%) 0 N/A 
 Pd630_RS25375 309/406 (76%) 0 N/A 
Pd630_RS34095 RHA1_ro02517 261/394 (66%) 3e-139 CatF 
 RHA1_ro01340 259/403 (64%) 2e-127 PcaF 
 RHA1_ro02863 229/412 (55%) 2e-70 PaaE 
 Pd630_RS31575 262/396 (66%) 1e-135 N/A 
 Pd630_RS25375 259/403 (64%) 1e-123 N/A 
 
Table 2-S13: Homology of aromatic degradation enzymes in Rhodococcus opacus PD630 to 
enzymes in Rhodococcus jostii RHA1 and Rhodococcus opacus 1CP. Protein sequences from 
R. opacus PD630 were compared to the R. jostii RHA1 and R. opacus 1CP protein sequences using 
NCBI blastp (https://blast.ncbi.nlm.nih.gov/Blast.cgi). The E value represents the number of hits 
expected by random chance when searching the database (the smaller value, the more significant 
match). The amino acid positive percent identity between each protein pair is reported as the 
number of identical or physically similar amino acids. If the protein has been characterized and 
named, the name is listed under notes. 
 
Fig. 2-5 genes (R. jostii RHA1) 
R. opacus PD630 
gene code 
Putative annotation 
R. jostii RHA1 
gene code 
R. jostii % positive 
identity 
R. jostii 
 E value 
Notes 
RS31555 
Two-component phenol hydroxylase, 
reductase component 
RHA1_ro02513 189/190 (99%) 3E-139 PheA2 
RS31560 
Two-component phenol hydroxylase, 
oxygenase component 
RHA1_ro02514 537/538 (99%) 0 PheA1 
RS30765 
Two-component phenol hydroxylase, 
reductase component 
RHA1_ro02379 184/186 (98%) 5E-139 N/A 
RS30770 
Two-component phenol hydroxylase, 
oxygenase component 
RHA1_ro02380 535/538 (99%) 0 N/A 
RS02665 
Putative vanillate demethylase, reductase 
component 
RHA1_ro04163 308/319 (96%) 0 N/A 
RS02670 Hypothetical protein RHA1_ro04164 69/71 (97%) 3E-33 N/A 
RS02675 
Putative vanillate demethylase, oxygenase 
component 
RHA1_ro04165 352/354 (99%) 0 N/A 
RS31670 TetR family transcriptional regulator RHA1_ro02538 208/208 (100%) 6E-150 N/A 
RS31675 4-hydroxybenzoate 3-monooxygenase RHA1_ro02539 390/392 (99%) 0 N/A 
RS30780 Cytochrome P450 RHA1_ro02382 401/403 (99%) 0 N/A 




RS21470 Hypothetical protein RHA1_ro02514 63/75 (84%) 3E-32 N/A 
RS21475 Cytochrome P450 RHA1_ro08068 380/440 (86%) 0 N/A 
RS21480 Putative cytochrome P450 reductase RHA1_ro11319 284/323 (87%) 0 N/A 
RS21485 Hypothetical protein none N/A N/A N/A 
RS30790 Benzoate 1,2 dioxygenase subunit A RHA1_ro02384 458/458 (100%) 0 BenA 
RS30795 Benzoate 1,2 dioxygenase subunit B RHA1_ro02385 167/169 (98%) 5E-124 BenB 
RS30800 
Benzoate 1,2 dioxygenase ferredoxin 
reductase 




RHA1_ro02387 262/264 (99%) 0 BenD 
Fig. 2-5 genes (R. opacus 1CP) 
R. opacus PD630 
gene code 
Putative annotation 
R. opacus 1CP 
gene code 




 E value 
Notes 
RS31555 
Two-component phenol hydroxylase, 
reductase component 
R1CP_30420 188/190(98%) 7e-139 PheA2 
RS31560 
Two-component phenol hydroxylase, 
oxygenase component 
R1CP_30425 536/538(99%) 0.0 PheA1 
RS30765 
Two-component phenol hydroxylase, 
reductase component 
R1CP_29650 185/186(99%) 1e-139 N/A 
RS30770 
Two-component phenol hydroxylase, 
oxygenase component 
R1CP_29655 534/538(99%) 0 N/A 
RS31670 TetR family transcriptional regulator R1CP_30540 207/208(99%) 3e-148 N/A 
RS31675 4-hydroxybenzoate 3-monooxygenase R1CP_30545 392/392(100%) 0 N/A 
RS30790 Benzoate 1,2 dioxygenase subunit A R1CP_29675 458/458 (100%) 0 BenA 
RS30795 Benzoate 1,2 dioxygenase subunit B R1CP_29680 169/169 (100%) 0 BenB 
RS30800 
Benzoate 1,2 dioxygenase ferredoxin 
reductase 




R1CP_29690 262/264 (99%) 0 BenD 
Fig. 2-6 genes 
R. opacus PD630 
gene code 
Putative annotation 
R. jostii RHA1 
gene code 












RHA1_ro01334 249/249 (100%) 0 PcaI 
RS25350 Protocatechuate 3,4-dioxygenase subunit A RHA1_ro01335 230/233 (98%) 1E-173 PcaH 
RS25355 Protocatechuate 3,4-dioxygenase subunit B RHA1_ro01336 211/213 (99%) 2E-152 PcaG 




RHA1_ro01338 393/400 (98%) 0 PcaC 
RS25370 IcIR family transcriptional regulator RHA1_ro01339 264/265 (99%) 0 PcaR 
RS25375 Putative 3-oxoadipyl-CoA thiolase RHA1_ro01340 401/403 (99%) 0 PcaF 
RS31565 Catechol 1,2-dioxygenase RHA1_ro02515 278/282 (98%) 0 CatA2 
RS31570 Putative 3-oxoadipate enol-lactonase RHA1_ro02516 257/264 (97%) 0 MhpC 
RS31575 Putative 3-oxoadipyl-CoA thiolase RHA1_ro02517 402/410 (98%) 0 CatF 
RS30720 ROK family transcriptional regulator RHA1_ro02370 396/397 (99%) 0 N/A 
RS30725 Muconolactone delta-isomerase RHA1_ro02371 92/93 (98%) 3E-65 CatC 
RS30730 Muconate cycloisomerase I RHA1_ro02372 370/373 (99%) 0 CatB 
RS30735 Catechol 1,2-dioxygenase RHA1_ro02373 279/280 (99%) 0 CatA 




Table 2-S14: Lignin model compound concentrations for Fig. 2-2 seed cultures and colony 
purification of adapted cultures. For the strains not used for Fig. 2, the listed concentrations can 
be used for their seed cultures. PCA = protocatechuate, GUA = guaiacol, PHE = phenol, HBA = 
4-hydroxybenzoate, VAN = vanillate, BEN = sodium benzoate, and GLC = glucose. * No.: 3 = P, 

















1 2 - - - - - - 
2 - 0.5 - - - - - 
3 - - 0.5 - - - - 
4 - - - 1 - - - 
5 - - - - 1 - - 
6 1 0.3 - - - - - 
7 1 - 0.3 - - - - 
8 1 - - 0.5 - - - 
9 1 - - - 0.5 - - 
10 - 0.3 0.3 - - - - 
11 - 0.3 - 0.5 - - - 
12 - 0.3 - - 0.5 - - 
13 - - 0.3 0.5 - - - 
14 - - 0.3 - 0.5 - - 
15 - - - 0.5 0.5 - - 
16 0.75 0.2 0.2 - - - - 
17 0.75 0.2 - 0.3 - - - 
18 0.75 0.2 - - 0.3 - - 
19 0.75 - 0.2 0.3 - - - 
20 0.75 - 0.2 - 0.3 - - 
21 0.75 - - 0.3 0.3 - - 
22 - 0.2 0.2 0.3 - - - 
23 - 0.2 0.2 - 0.3 - - 
24 - 0.2 - 0.3 0.3 - - 
25 - - 0.2 0.3 0.3 - - 
26 0.5 0.1 0.1 0.2 - - - 
27 - 0.1 0.1 0.2 0.2 - - 
28 0.5 - 0.1 0.2 0.2 - - 
29 0.5 0.1 0.1 - 0.2 - - 
30 0.5 0.1 - 0.2 0.2 - - 
31 0.4 0.1 0.1 0.1 0.1 - - 
32 - - - - - - 100 





Table 2-S15: Lignin model compound concentrations for Fig. 2-2 subcultures. For the strains 
not used for Fig. 2, the listed concentrations can be used for their subcultures. PCA = 
protocatechuate, GUA = guaiacol, PHE = phenol, HBA = 4-hydroxybenzoate, VAN = vanillate, 
BEN = sodium benzoate, and GLC = glucose. * No.: 3 = P, 14 = PV, 25 = PVH, 27 = PVHG, 32 

















1 2.29 - - - - - - 
2 - 0.84 - - - - - 
3 - - 0.75 - - - - 
4 - - - 1.54 - - - 
5 - - - - 1.03 - - 
6 1.42 0.24 - - - - - 
7 1.66 - 0.28 - - - - 
8 1.32 - - 0.44 - - - 
9 1.62 - - - 0.54 - - 
10 - 0.32 0.32 - - - - 
11 - 0.15 - 0.53 - - - 
12 - 0.55 - - 0.55 - - 
13 - - 0.52 0.52 - - - 
14 - - 0.58 - 0.58 - - 
15 - - - 0.70 0.70 - - 
16 0.67 0.11 0.11 - - - - 
17 1.45 0.24 - 0.24 - - - 
18 1.59 0.27 - - 0.27 - - 
19 1.07 - 0.18 0.18 - - - 
20 1.59 - 0.27 - 0.27 - - 
21 1.13 - - 0.38 0.19 - - 
22 - 0.30 0.30 0.59 - - - 
23 - 0.17 0.17 - 0.34 - - 
24 - 0.33 - 0.66 0.66 - - 
25 - - 0.24 0.49 0.49 - - 
26 0.68 0.11 0.11 0.23 - - - 
27 - 0.25 0.25 0.49 0.49 - - 
28 0.77 - 0.13 0.26 0.26 - - 
29 1.49 0.25 0.25 - 0.50 - - 
30 0.76 0.13 - 0.25 0.25 - - 
31 0.75 0.13 0.13 0.25 0.25 - - 
32 - - - - - - 210 





Table 2-S16: Summary of heterologous plasmids used in this work.   
 









pDD120 pConstitutive.Che9c60.Che9c61 pB264 Kanamycin 6247 
Delorenzo et al. 
2018 [139] 
pDD163 RS30730 knockout vector Integrative/p15a Hygromycin B 3268 This study 
pDD174 RS25360 knockout vector Integrative/p15a Gentamicin 4249 This study 
pDD175 RS30810 knockout vector Integrative/p15a Hygromycin B 3373 This study 
pDD176 RS33590 knockout vector Integrative/p15a Hygromycin B 3336 This study 
pDD177 RS031355 knockout vector Integrative/p15a Hygromycin B 3327 This study 
Strain 
name 





DMD155 Escherichia coli DH10B pDD120 N/A 
DMD250 Escherichia coli DH10B pDD163 N/A 
DMD251 Rhodococcus opacus PD630 pDD163 Fig. 6C 
DMD258 Escherichia coli DH10B pDD177 N/A 
DMD270 Escherichia coli DH10B pDD174 N/A 
DMD274 Escherichia coli DH10B pDD175 N/A 
DMD275 Escherichia coli DH10B pDD176 N/A 
DMD281 Rhodococcus opacus PD630 pDD174 Fig. 6D 
DMD282 Rhodococcus opacus PD630 pDD177 Fig. S18 
DMD283 Rhodococcus opacus PD630 pDD175 Fig. S18 
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The microbiome and resistome of 
chimpanzees, gorillas, and humans across 
lifestyle and geography 
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 The gut microbiome is generally stable but can vary across differences in host lifestyle, 
geography, and host species. By comparing closely related host species across varying locations 
and geography we can evaluate the relative contributions of these factors in structuring the 
composition and functions of the microbiome. Here we show that the gut microbiome and 




shotgun and functional metagenomics, we show that captive chimpanzees and gorillas have an 
enrichment of microbial genera commonly found in non-Westernized humans despite living in 
close geographic proximity to Westernized humans. Captive apes also maintain higher richness 
and abundance of antibiotic resistance genes compared to wild apes. Finally, by comparing our 
study cohorts to human gut microbiomes from a diverse range of environments and lifestyles, and 
to other wild and captive gorilla cohorts, we find that the influence of host lifestyle is robust to 
various geographic locations. 
3.2 Introduction 
 
From an anthropocentric view, the microbiomes of great apes provide a view to our 
evolutionary past [140-142]. Gut microbial communities are generally stable, but they can be 
altered in accordance with several factors including host lifestyle [140, 143-151], host species 
[141, 142, 152], and geography [153-155]. By comparing microbial variation in wild and captive 
great apes, we can approximate changes that occurred in human modernization as human 
microbiomes were influenced by changes in lifestyle, including an increasingly Westernized diet 
and increased antibiotic usage [140]. Such comparisons are also important for understanding the 
impact of humans and their activities on great ape health. Anthropogenic threats such as poaching, 
habitat encroachment, and diseases are the primary causes of population decrease in these 
endangered Hominidae species, and the risk to great ape populations of exposure to human 
activities continues to increase [154, 156-159].  
The taxonomic composition of microbiomes of captive primates from the United States, 
Southeast Asia, and Costa Rica have been shown to cluster with those of geographically separated 
non-Westernized humans [143]. By synchronous sampling of a non-Westernized human cohort 




species, lifestyle, or geographic distance [140, 160]. These findings can help guide conservation 
efforts in endangered animals aimed at promoting microbiome configurations that are linked with 
optimal host health and metabolism [161]. Such insight will not only inform the well-being of 
captive populations but can lead to improved conservation outcomes in rehabilitation and 
reintroduction programs [162].  
 Antibiotic exposure represents a key lifestyle-associated factor which can acutely and 
persistently alter the gut microbiome [145, 151, 163]. Because of their ability to kill or inhibit the 
growth of virtually all microbes, antibiotic treatments provide strong selection for enrichment of 
antibiotic resistance genes (ARGs), selecting for and leading to an increasingly antibiotic resistant 
bacterial composition [164, 165]. However, ARGs can also be found in bacteria from pristine 
environments naïve to human-produced antibiotics, most likely due to the selection pressure 
provided by natural antibiotic secretion from environmental bacteria and fungi over long 
evolutionary time-scales [145, 166]. The discovery, and often indiscriminate usage, of antibiotics 
in human and agricultural settings over the past century has selected for dramatic enrichment and 
transmission of ARGs between environmental, commensal, and pathogenic microbes from diverse 
habitats [145, 167]. Proactive identification of ARGs in environmental and host-associated 
microbiomes allows for their characterization, tracking, and potential inhibition before they can 
be exchanged with pathogens and found in the clinic [163, 168, 169]. Characterization of the 
antibiotic resistome of wild and captive non-human primates can help approximate how the human 
resistome may have changed in the antibiotic era, as well as assess the impact of human-contact 
and captivity on the primate gut resistome [145, 151]. 
 Here we compare the fecal microbiome taxonomic composition, microbial functional 




humans living in the same geographical region as the wild apes. We also compare these cohorts 
with human cohorts from around the world representing diverse lifestyles and geographies [144, 
146, 147, 163, 170]. We hypothesize that the gut microbiomes, functional pathways, and 
resistomes of sympatric humans and apes will be similar to each other since sharing of gut 
microbiota between humans and wild and domestic animals living in geographic proximity has 
been shown previously [154, 155, 171]. We further hypothesize that captive chimpanzees and 
gorillas from zoos in the United States will be most similar to Westernized human microbiomes 
because of human exposure and antibiotic treatment.  
 In this study we used high-throughput metagenomic sequencing to characterize the gut 
microbiota and resistomes of 18 wild central chimpanzees (Pan troglodytes troglodytes) and 28 
wild western lowland gorillas (Gorilla gorilla gorilla) from Nouabalé-Ndoki National Park in the 
Republic of the Congo. These wild animals live in a remote area of the park that was completely 
naïve to human impact before 2003 and identified as the ape population that was least disturbed 
by humans in 2014 [172, 173]. We also collected samples from 81 humans living just outside of 
the park, including some individuals that work within the park, in the Republic of the Congo. We 
compared these cohorts to 18 chimpanzees and 15 western lowland gorillas from the St. Louis Zoo 
(St. Louis, MO) and the Lincoln Park Zoo (Chicago, IL) in the United States. To tease apart the 
contribution of lifestyle, location, and host species, our study includes two lifestyles (wild hunter-
gatherer and non-Western human), two locations (USA and the Republic of the Congo), and three 
host species (human, chimpanzee, and gorilla). To determine if our results are robust to further 
differences in lifestyles and locations, we compared the fecal microbiomes from our samples to 
published hunter-gatherer, rural agriculturalist, and urban human cohorts from the USA [146, 174], 




to published wild and captive gorilla cohorts from the Republic of the Congo, the USA, France, 
and Switzerland [140, 175]. 
3.3 Results & Discussion 
3.3.1 Taxonomic composition of the gut microbiome was predominantly 
influenced by lifestyle 
 
To test our hypothesis that the microbiomes of sympatric hosts will be the most similar, 
we sequenced microbial metagenomic DNA from the fecal samples of our wild chimpanzee and 
gorilla cohorts from the Republic of the Congo, humans living in close proximity, and captive 
chimpanzees and gorillas from zoos in the USA. Overall, we generated 10.4 million sequences of 
the V4 region of the 16S ribosomal RNA gene from 160 samples, which we analyzed as exact 
amplicon sequence variants (ASVs). Through Principal Coordinates Analysis (PCoA), we found 
that captive chimpanzees and gorillas clustered more closely with the non-Westernized humans 
than their wild counterparts, indicating more human-like microbiomes (Figures 3-1A, 3-S1A). 
Despite living in close geographic proximity, the humans, wild chimpanzees, and wild gorillas live 
vastly different lifestyles as characterized by diet and antibiotic usage. Wild chimpanzees and 
gorillas both eat natural plants and have some overlap in their diets, but chimpanzees are frugivores 
while gorillas are predominantly folivores [176-178]. The humans in this study are rural 
agriculturists and eat non-Westernized diets, high in plant fiber and low in animal protein, and are 
exposed to antibiotic treatments that can further alter the gut microbiome [149, 179, 180]. The 
captive apes have similar diets and a similar degree of antibiotic treatment as non-Westernized 
humans which most likely drive the similarities in humans and captive apes [181]. This provides 





Figure 3-1: Taxonomic composition of the human, chimpanzee, and gorilla gut microbiomes. 
(A) Principal-coordinate analysis (PCoA) plot of Bray-Curtis 16S metagenomic profiles from 
individual human, chimpanzee, and gorilla fecal samples. (B) PCoA plot of Bray-Curtis 16S 
metagenomic profiles from individual chimpanzee and gorilla fecal samples. (C) Boxplot of ASV 
richness in host microbiomes (Kruskal-Wallis sum-rank test P < 3.8e-14; Wilcoxon rank sum test 
with Benjamini-Hochberg correction P  7.7e-4). (D) Relative abundances of major bacteria phyla 
for all individuals. (E) Cladogram of discriminatory taxa identified in human, chimpanzee, and 
gorilla microbiome 16S data sets. Clades significantly enriched in human (red nodes), captive 
chimpanzee (green nodes), captive gorilla (blue nodes), wild chimpanzee (purple nodes), and wild 
gorilla (light blue nodes) metagenomes are indicated (LEfSe; linear discriminant analysis (LDA) 




geography or host species. These findings are consistent with previous comparisons between 
captive and wild douc and howler monkeys as well as comparisons between non-Westernized and 
Westernized humans [143, 180].  
The captive ape microbiomes all clustered more closely together than wild apes despite 
being housed in two zoos ~500 km apart (Figure 3-1B). This finding is in contrast to a previous 
study where the gut microbiomes of wild sympatric chimpanzees and gorillas were more similar 
than wild allopatric apes [153]. Comparisons of sympatric and allopatric wild apes may be 
confounded by the underlying changes in plants that are available for consumption in the different 
locations. In contrast, the relatively limited diversity in human agriculture limits the diets for 
captive apes and non-Westernized humans influencing their microbiomes to become more similar 
[182]. Host species appeared to have some effect on the gut microbiome since wild and captive 
chimpanzee microbiomes clustered more closely to humans than the respective wild and captive 
gorillas. Chimpanzees are evolutionarily more closely related to humans than gorillas are, and that 
relatedness is maintained in their gut microbiome in these findings [141, 142]. 
To identify differences in alpha diversity, we compared the species richness and Shannon 
diversity of microbiomes in our cohort. We found that captive apes in the USA had higher richness 
of ASVs (Figure 3-1C) following a geographic pattern, while humans and chimpanzees had higher 
Shannon diversity than gorillas following a pattern of being influenced by host species (Figures 3-
1C, 3-S1B). Shannon diversity takes into account species evenness, with lower Shannon values 
indicating either decreased richness, decreased evenness, or both. Since captive apes have higher 
species richness but similar Shannon values to wild apes, their microbiomes must contain a high 
number of rare ASVs. Previous studies have reported that captivity is typically associated with a 




that pattern depending on the population studied [143, 183]. In support of this, a previous study 
found no significant difference in the Shannon diversity of wild and captive gorillas [175]. 
We used linear discriminant analysis effect size (LEfSe) [184] analysis to identify specific 
taxa that are enriched in each host microbiome and found that captivity is associated with a higher 
abundance of Prevotella (Bacteroidetes) and Treponema (Spirochaetes) for both chimpanzees and 
gorillas (Figures 3-1D,E, 3-S1D,E). Prevotella was also found in high abundance in the Congolese 
human microbiomes we sampled. Increased colonization of Prevotella and Treponema in captive 
animal microbiomes and non-Westernized humans has been observed previously and is often 
attributed to host diet [143, 149]. Species within the genus Prevotella are capable of plant 
polysaccharide degradation, exhibiting ß-D-xylanase and ß-xylosidase activities which are 
associated with hemicellulose degradation [143, 149]. Increased abundance of Prevotella in 
captive apes suggests that their increased abundance may be caused by differences in the 
composition of dietary polysaccharides compared to wild apes [143]. We were able to identify 
three Treponema ASVs at the species level: Treponema succinifaciens, Treponema bryantii, and 
Treponema berlinense. These species of Treponema are considered non-pathogenic commensals 
that metabolize complex polysaccharides found in unprocessed plants [185, 186]. Commensal 
Treponema species have been found in high abundance in human populations with non-
Westernized lifestyles, including Hadza hunter-gatherers in Tanzania [148], Matses hunter-
gatherers in the Peruvian Amazon [146],  humans practicing traditional agriculture in the 
Tunapuco community of the Peruvian Andean highlands [146], and BaAka pygmies in the Central 
African Republic [149]. Due to its presence in non-Westernized human populations and absence 
in Westernized humans, Treponema has been postulated to be a member of the ancestral human 




hypothesis since they indicate that this genus is naturally shared in our evolutionarily nearest living 
relatives. The much higher abundance in captive apes compared to wild apes indicates that 
Treponema species may be optimized to metabolize plant polysaccharides from the human diet 
[146].  
In contrast, wild chimpanzees were distinguished by higher relative recovery of 
Coriobacteriaceae (Actinobacteria) and two families from the phylum Firmicutes: 
Erysipelotrichaceae and Lachnospiraceae (Figures 3-1E, 3-S1D). Wild gorillas had higher relative 
recovery of Mogibacteriacea (Firmicutes) and SHD-231 (Chloroflexi), an under-characterized 
bacterial genus found previously in wild western lowland gorilla microbiomes [140] (Figures 3-
1D, 3-S1E). SHD-231 appears to be found only within the gorilla microbiome, indicating that it 
may have co-evolved with the gorilla microbiome.   
3.3.2 Functional pathways in the microbiome are relatively robust to changes 
in individual taxa 
 
 To determine how differences in microbiome taxonomy altered functional potential, we 
performed whole metagenome shotgun sequencing on all 160 fecal samples, rarefied the resulting 
sequences to four million paired-end reads per sample, and annotated functional pathways using 
HUMAnN2 [35]. We found that lifestyle had less influence on functional pathways in the 
microbiome than on taxa (Figures 3-2A, 3-S2A,B). Functional pathways may be robust to changes 
in taxa since many pathways are redundant across microbial taxa[35]. Using LEfSe, we identified 
several discriminatory pathways that showed varying patterns of association with lifestyle and host 
species (Figures 3-2B, 3-S2C). Captive and wild apes had higher relative recovery of branched 
amino acid synthesis pathways (including isoleucine and valine) compared to humans, with 




(Figure 3-2B). This indicates that the non-Westernized lifestyle is associated with decreasing 
branched amino acid synthesis but the large difference in ape and human relative abundance 
indicates that host species also influences these changes. Congolese humans had the highest levels 
of lysine and aromatic amino acid synthesis with relative abundance decreasing along both the 
gradient of non-Westernized human to wild ape lifestyles, and host species relatedness with 
relative abundance decreasing as the relatedness to humans decreased.  
 
Figure 3-2: Functional pathway analysis of gut microbiota. (A) PCoA plot of Bray-Curtis 
distances of the relative abundance of functional pathways from HUMAnN2 results. (B) Relative 
abundance of functional pathways involved in amino acid synthesis, peptidoglycan synthesis, and 
carbohydrate degradation (Kruskal-Wallis sum-rank test for all plots P  3.2E-9; Wilcoxon rank 
sum test with Benjamini-Hochberg correction, for significant differences in all plots P  0.047). 
The superpathway of purine synthesis I and adenosine synthesis was highest in the wild 
gorillas and may be associated with the SHD-231 family, as a previous study also found increased 
nucleotide sugar biosynthesis and purine nucleotide salvage pathways in gorilla microbiomes 
dominated by SHD-231 [140]. We next investigated carbohydrate degradation pathways and found 
that Congolese human microbiomes were enriched for the degradation of starch, galactose, and 




becomes more different from the non-Westernized human lifestyle. For galactose and stachyose 
degradation, host species influenced relative recovery as captive and wild chimpanzees had no 
difference in relative recovery, but wild gorillas had decreased abundances compared to captive 
gorillas. The relative abundance of the starch degradation pathway shows a clear pattern of being 
influenced by host lifestyle. Starch consumption is the main source of calories in humans, while 
wild chimpanzees and gorillas consume low starch diets [181, 187]. Starch and carbohydrate 
degradation have been linked with the presence of Treponema and Prevotella. These genera may 
be the predominant taxa providing these functions in our cohorts since they are also enriched in 
humans and captive apes in this study [140, 143]. 
3.3.3 Microbial resistome is primarily influenced by host lifestyle 
 
 To probe for antibiotic resistance genes (ARGs) that were putatively unique to our cohorts, 
we used functional metagenomics, a method where metagenomic DNA fragments are cloned into 
expression vectors, transformed into E. coli, and the resultant transformants are tested for 
phenotypic resistance using antibiotic selection [12, 151, 163]. From our 160 samples, we created 
16 functional libraries containing 50-123 gigabases of total insert DNA and screened them on 15 
different antibiotics or antibiotic combinations resulting in the annotation of 332 ARGs (Figure 3-
3A, Table 3-S1). We combined these resulting protein sequences with ARG protein sequences 
from the Comprehensive Antibiotic Resistance Database (CARD) [188], and used ShortBRED 
[36] to create unique markers for ARG identification in the 640 million shotgun metagenomic 
reads (4 million per sample) originating from ape and human fecal DNA. We found that captive 
apes clustered more closely to humans than wild apes for both abundance and presence of ARGs 




more closely together than wild apes (Figures 3-3B,C). This provides evidence that host lifestyle 
influences the gut resistome more than geography or host species for the studied primates. 
Aminoglycoside resistance genes represented more than 50% of the wild ape gut 
resistomes (Figure 3-3C). Aminoglycosides are produced naturally in the environment by several 
soil bacteria and inhibit protein synthesis by binding to the ribosome [189]. The specific 
aminoglycoside resistance genes we found enriched in wild apes were identified as AAC(3)-VIIa, 
an acetyltransferase that inactivates aminoglycosides [189], and FmrO ribosomal RNA 
methyltransferases [190] that were identified from our functional selections. Ribosomal 
methyltransferases provide aminoglycoside resistance by methylation of the ribosome that 
prevents aminoglycoside binding and thus resistance [191]. The overall abundance and richness 
of ARGs in wild apes was extremely low compared to humans and captive apes (Figure 3-3D). In 
captive apes and humans, tetracycline resistance genes were the most abundant with beta-lactams 
also making up a large proportion of the resistome (Figure 3-3C). Tetracyclines and beta-lactams 
are both broad-spectrum antibiotics and are popular first-line antibiotics in human infectious 
disease treatment [192]. Tetracycline resistance in the human and captive ape cohorts was 
conferred predominantly by six different ribosomal protection genes identified through 
tetracycline functional selections and beta-lactam resistance was dominated by high recovery of 
CfxA4, a beta-lactamase. Captive apes had up to ~34-fold higher abundance and up to ~5-fold 
higher richness of all ARGs compared to wild apes (Figures 3-3D,E). The most parsimonious 
explanation for the higher observed burden of ARGs in captive apes compared to wild apes is the 
higher selection pressure from antibiotic treatment of the captive apes. We had limited access to 
antibiotic treatment records for captive apes but the records we do have indicate that captive apes 




Congolese human microbiomes had the highest abundance and richness of ARGs with ~3-fold 
higher abundance and ~2-fold higher richness compared to the next highest cohort (Figures 3-
3D,E). Host lifestyle appears to be the driving force for ARG abundance and richness in these 
analyses. 
 
Figure 3-3: The antibiotic resistome of humans, chimpanzees, and gorillas. (A) PCoA plot 
using Bray-Curtis distances of ARG abundance normalized with RPKM from ShortBRED results 
of human, chimpanzee, and gorilla resistomes. (B) PCoA plot using Bray-Curtis distances of ARG 
richness (presence/absence) from ShortBRED results of human, chimpanzee, and gorilla 
resistomes. (C) Relative abundances of major classes of antibiotic resistance averaged by host 
cohort. (D) Sum of all ARG marker abundances per metagenome based on markers generated from 
the CARD database and functional selections, expressed in log transformed RPKM (Kruskal-
Wallis sum-rank test P < 2.2e-16; Wilcoxon rank sum test with Benjamini-Hochberg correction P 
 1.2e-5). (E) Resistome richness per metagenome (Kruskal-Wallis sum-rank test P < 2.2e-16; 
Wilcoxon rank sum test with Benjamini-Hochberg correction P  0.049). (F) Alignment of an 
ARG containing DNA fragment with high similarity across host cohorts obtained from functional 
metagenomic selections. (G) Histogram of amino acid identity to known ARGs for aminoglycoside 
resistance genes identified through functional metagenomic selections. Colors indicate from which 




3.3.4 Functional metagenomic selections identified novel antibiotic resistance 
genes 
 
 One major advantage of functional metagenomic analysis is the ability to identify novel 
ARGs from metagenomic DNA without the need for high sequence identity to known ARGs [12, 
151, 163]. This allows for the characterization and surveillance of identified ARGs before they 
become clinically disseminated [163, 167, 193]. Since wild ape resistomes were dominated by 
aminoglycoside resistance, we explored proteins annotated as aminoglycoside resistance from our 
functional selections on ape microbiomes. From these selections, we identified 19 aminoglycoside 
resistance methyltransferases that belonged to the FmrO family. When compared to known ARGs 
in the CARD database, we found that they all aligned to 16S rRNA methyltransferases, such as 
rmtC, rmtD, rmtF, rmtH, or sgm. The percent similarity of these genes to known ARGs ranged 
from 29-98%, indicating that some of these genes have not been identified previously (Figure 3-
3G).  
Additionally, we found a total of nine contigs from functional metagenomic selections 
containing ARGs that were shared either across host species or captivity status demonstrating that 
Congolese human microbiomes harbor some of the same ARGs as wild and captive ape 
microbiomes (Figures 3-3F, 3-S4). One ~2 kb contig that was particularly widespread between 
different hosts contained a PenP beta-lactamase located between two mobile elements, an 
integrase and a tnpR resolvase, indicating a high potential for horizontal gene transfer [194, 195].  
Highly similar copies (>99% similarity) of this PenP-containing contig were found in functional 
libraries created from every research cohort in this study except for wild chimpanzees. This gene 
may be widespread either because it is contained in a widespread bacterial taxon, has spread to 




the nine PenP-containing contigs identified, three contained ARGs co-localized with mobile 
elements. Identification of ARGs in captive and wild apes indicates that ape microbiomes may 
serve as a zoonotic reservoir of antibiotic resistance that may be exchanged with human associated 
microbes [169]. Importantly, identification of similar ARGs in human and ape populations also 
indicates that the human microbiome may serve as a reservoir for ARG acquisition by great ape 
microbiomes. Transmission of microorganisms between humans and great apes in both directions 
is well documented, with several pathogens exhibiting zoonotic or anthropozoonotic patterns [154, 
156-159, 171, 183, 196, 197]. Transmission of microorganisms also results in transfer of the ARGs 
that those organisms contain. Identification and characterization of reservoirs of ARGs in humans 
and other closely related Hominidae species, including wild and captive populations, allows for a 
proactive approach to combat antibiotic resistance via surveillance and targeted infection control 
measures [198-200]. These transmission events are likely to rise as humans and great apes are 
increasingly brought into contact with each other through ecotourism, human population growth 
near conservation areas, and civil unrest [154, 156, 183, 201, 202]. 
We also identified an ARG conferring resistance to colistin, an antibiotic of last-resort, 
from a Congolese human derived functional metagenomic library (Figure 3-S3A). The identified 
contig contained a gene annotated as a member of the type 2 phosphatidic acid phosphatase (PAP2) 
superfamily that, when isolated and expressed in a pZE21 plasmid backbone, conferred a minimal 
inhibitory concentration of 4 µg/ml to colistin in E. coli. This represents an ~85-fold increase in 
resistance compared to the empty vector control (Figure 3-S5A). An MIC of 4 µg/ml exceeds the 
2 µg/ml resistant/susceptible breakpoint in Enterobacteriaceae according to the European 
Committee on Antimicrobial Susceptibility Testing (EUCAST), indicating this level of resistance 




targeting the lipid A portion of lipopolysaccharide leading to disruption of the outer cell membrane 
and ultimately cell death [203]. Resistance is typically conferred by modification of lipid A by 
addition of chemical moieties to LPS, preventing colistin binding. For example, a clinically 
relevant colistin resistance gene, mcr-1, provides colistin resistance by adding a 
phosphoethanolamine moiety to LPS [198]. We predict that the PAP2 gene from this study either 
alters LPS by adding a chemical moiety onto LPS or by altering the composition of the cell 
membrane to include less LPS. 
Using BLAST, we identified two proteins similar to the PAP2 gene product in the NCBI 
non-redundant protein database. One was discovered from published functional metagenomic 
selections on colistin [163] (98.62% identity and 76% coverage) and the other came from a 
Prevotella sp. genome assembled from metagenomic samples [204] (98.88% identity and 95% 
coverage) (Figure 3-S5B). After these two similar proteins there is a sharp drop in identity with 
the next closest proteins also coming from Prevotella hosts (Figure 3-S5B). Bacteria from the 
genus Prevotella are generally considered to be commensal to humans, so colistin resistance in 
this genus is not particularly troublesome. However, continued usage of colistin increases the 
selection pressure and possibility of horizontal gene transfer of this gene to pathogenic strains. 
Indeed, mcr-1 originated from non-pathogenic species within the genus Moraxella and has since 
spread to human and animal pathogens in the Enterobacteriaceae family [205-207]. The 
identification of this PAP2 colistin resistance gene from a functional metagenomic selection allows 
time for the characterization and surveillance of this gene before it is transmitted to human or 
animal pathogens. 
3.3.5 Captive ape microbiomes and resistomes cluster closely with non-





 To contextualize the microbiomes from our cohorts within a diverse group of human 
lifestyles and environments, we compared our samples to publicly available human and ape gut 
microbiomes. We included sequencing data that also targeted the V4 region of the 16S rRNA gene 
from Westernized and non-Westernized humans. Westernized humans include data from humans 
in the USA [144] (n = 20) and a peri-urban slum of Lima, Peru [163] (n = 20). The non-
Westernized humans can be grouped into a rough gradient of Westernization with the human 
cohort from this study in the Republic of the Congo (n = 81), rural farmers in El Salvador [163] (n 
= 20) and farmers in Malawi [144] (n = 20) having intermediate Westernization, and Hadza hunter-
gatherers [170] (n = 20) and Guahibo Amerindians [144] (n = 20) being the least Westernized. We 
also included a study of great ape microbiomes that used the V4 region of the 16S rRNA gene that 
analyzed captive gorillas from zoos in the USA, France, and Switzerland [175] (n = 8). Analysis 
of the microbial composition of the gut microbiome by PCoA resulted in Westernized and non-
Westernized humans clustering by lifestyle despite differences in geographic location. Contrary to 
our initial hypothesis that non-human primates would cluster with humans living near them, 
captive apes clustered near the non-Westernized humans that shared a similar lifestyle, and wild 
apes clustered separately (Figures 3-4A, 3-S6A). Some samples of the published captive gorilla 
cohort clustered with our captive gorillas while others were intermediate between captive and wild 
apes. Alpha diversity, as measured by ASV richness and Shannon diversity, demonstrated no 
apparent pattern of westernization, but USA humans did have the lowest richness and among the 
lowest Shannon diversity, as has been demonstrated previously (Figure 3-4B, 3-S6C) [142, 183, 
208]. Overall, we observed that the patterns of clustering we observed in our initial analysis are 




 We accessed published shotgun metagenomic sequencing data from similar human and 
gorilla cohorts for resistome and functional pathway analysis. Westernized human sequencing data 
was obtained from humans in Norman, USA [146] (n = 20) and the peri-urban slum in Lima, Peru 
[163] (n =14). Non-Westernized humans included the Tunapuco community in the Peruvian 
Andean highlands [146] (n = 10), rural farmers in El Salvador [163] (n = 9), Hadza hunter-
gatherers from Tanzania [147] (n = 20), and humans from this study in the Republic of the Congo 
(n = 81). We also included a cohort of wild gorillas (n = 19) from the Sangha region of the Republic 
of the Congo, a sample site with higher human disturbance [140] than our study site that is ~200 
km away. By obtaining shotgun metagenomic sequences we were able to compare differences in 
the gut microbiome functional pathways and resistome. 
Functional pathways were robust to differences in geographic location with captive apes 
continuing to cluster between wild apes and humans (Figures 3-4C, 3-S6C).  All human cohorts 
clustered closely together despite coming from different countries throughout the world. In fact, 
there was no significant difference in the compositions of the Hadza and Tunapuco cohorts 
(pairwise adonis, P = 0.08) and between the Tunapuco and El Salvador cohorts (pairwise adonis, 
P = 0.06). Wild chimpanzees and wild gorillas also had no significant differences in gut 
microbiome composition (pairwise adonis, P = 0.42). The gorillas from the Sangha region 
generally clustered with wild ape samples from this study with a few samples clustering separately, 
possibly representing samples from different seasonal diets not represented in our data [140]. 
Overall, all samples had decreased Bray-Curtis distances compared to taxonomic distances, most 
likely due to redundant functional pathways found across microbial taxa (Figure 3-S6C).  
Resistome composition generally clustered by degree of Westernization but had less clear 





Figure 3-4: Comparison of chimpanzee and gorilla microbiomes to human microbiomes 
across a wide range of lifestyle and environment. (A) PCoA plot of Bray-Curtis 16S 
metagenomic profiles. (B) ASV richness of host human, chimpanzee, and gorilla microbiomes 
(Kruskal-Wallis sum-rank test P < 2.2e-16; Wilcoxon rank sum test with Benjamini-Hochberg 
correction P  0.021). (C) PCoA plot using Bray-Curtis distances of the relative abundance of 
functional pathways from HUMAnN2 results. (D) PCoA plot of Bray-Curtis distances of ARG 
abundance normalized with RPKM from ShortBRED results. Two wild chimpanzee samples and 
one wild gorilla sample were removed from this PCoA analysis because the lower rarefaction level 
used for comparison with public data resulted in no ARGs detected for these samples and no Bray-
Curtis distances could be calculated. (E) Sum of all ARG marker abundances per metagenome 
expressed in log transformed RPKM (Kruskal-Wallis sum-rank test P < 2.2e-16; Wilcoxon rank 
sum test with Benjamini-Hochberg correction P  0.034). (F) Resistome richness per metagenome 
(Kruskal-Wallis sum-rank test P < 2.2e-16; Wilcoxon rank sum test with Benjamini-Hochberg 
correction P  0.049). 
3-4D, 3-S6D). Captive chimpanzee and captive gorilla resistomes were not significantly different 




gorilla resistomes were not significantly different from each other (pairwise adonis, wild 
chimpanzee vs. wild gorilla, P = 0.63, wild chimpanzee vs. Sangha gorilla, P = 0.18, wild gorilla 
vs. Sangha gorilla, P = 0.10) demonstrating that host species is less influential in resistome 
composition than lifestyle.  
Hadza hunter-gatherers had the highest ARG abundance of all groups analyzed, followed 
by the other human cohorts, captive apes, and then finally wild apes with the lowest abundance 
(Figure 3-4E). All the human cohorts from developing countries had high ARG richness with wide 
variance except for the El Salvador human cohort (Figure 3-4F). Antibiotic resistance may be high 
in developing countries for a number of reasons, including: a high burden of infectious disease, 
poor sanitation, and less regulation of antibiotic compounds [209].  Wild apes had the lowest levels 
of ARGs with captive apes also generally having lower levels of ARG richness and abundance 
than humans. Lifestyle may be the most influential factor of resistome composition, but host 
species appears to play a role in ARG alpha-diversity metrics. 
 In conclusion, contrary to our hypothesis sympatric hosts did not have the most similar gut 
microbiome composition. Host lifestyle appears to be more influential than host geography or host 
species at structuring taxonomic and resistome composition. However, functional pathway 
composition and alpha-diversity metrics of taxonomy and the resistome appear to be influenced 
by host species and geography. Further, captive ape microbiomes clustered with non-Westernized 
humans despite living in close proximity to Westernized humans. Our findings indicate that the 
microbiome of closely related host species may be molded by changes in diet and the degree of 




3.4 Materials and Methods 
3.4.1 Sample Collection 
 
Wild ape fecal samples were collected in the Goualougo Triangle region of Nouabalé-
Ndoki National Park in the Republic of the Congo. Samples were collected in the morning from 
overnight nesting sites from habituated chimpanzees and gorillas and matched to metadata for the 
animal that occupied the nest. Human samples were collected from humans living outside of the 
national park boundaries, including and surrounding the village of Bomassa. Captive ape samples 
were collected from the Lincoln Park Zoo and the St. Louis Zoo. All sample collection was 
performed with informed consent for the human participants and in accordance with ethics 
approval by le Comité d’Ethique de la Recherche en Sciences de la Santé (CERSSA) in the 
Republic of the Congo. Samples were kept in cold storage on dry ice until shipment to Washington 
University in St. Louis, where they were stored at -80 °C until processing.  
3.4.2 DNA Extraction and Library Preparation 
 
 DNA was extracted from 100 mg of each fecal sample using a PowerSoil DNA Isolation 
Kit (MoBio) with a Mini-beadbeater (BioSpec Products) for the lysis step and stored at -20 °C. 
Target metagenomic sequencing libraries were created by amplifying the V4 region of 16S rRNA 
genes using 515F-806R barcoded primers and PCR protocols described previously [210]. Bar-
coded amplicons were pooled and sequenced on an Illumina MiSeq sequencer with 2 × 250-bp 
paired-end reads. Shotgun metagenomic sequencing libraries were prepared by diluting extracted 
DNA to 0.5 ng/µl and using a Nextera DNA Library Prep Kit (Illumina) following the 
modifications described in Baym et al. to generate ~450 bp segments [122]. DNA fragments were 




the Quant-iT PicoGreen dsDNA assay (Invitrogen). For each sequencing lane, 10 nM of 
approximately 80 samples were pooled three independent times. The resulting pools were 
quantified using the Qubit dsDNA BR Assay and equimolar concentrations were combined. 
Samples were sequenced on an Illumina NextSeq High-Output platform at the Edison Family 
Center for Genome Sciences and Systems Biology at Washington University School of Medicine 
in St. Louis, with a target sequencing depth of 4 million 2 × 150-bp paired-end reads per sample. 
3.4.3 16S and shotgun metagenomics bioinformatics analysis 
 
 Barcoded 16S Illumina reads were demultiplexed and barcodes were removed using 
QIIME v1.9 [174]. No significant differences were found in sequencing depth between host 
cohorts, so samples were not rarefied (Kruskal-Wallis, P = 0.18; Figure 3-S1C). Phylogenetic 
analysis was performed using dada2 v1.8 [211] according to the recommended pipeline. The 
resulting ASVs were assigned taxonomy using the Greengenes database [212] (version 13_8, 97% 
clusters). Principal Coordinate Analysis plots were generated using Bray-Curtis distances on 
sequence counts normalized by relative abundance and significance testing was performed using 
Adonis. No normalization was performed before alpha-diversity analysis. Significance testing for 
alpha-diversity was performed using the non-parametric Kruskal-Wallis Rank Sum test and the 
Pairwise Wilcoxon Rank Sum test using the Benjamini-Hochberg correction for multiple testing. 
Groups were considered significantly different if the resulting P-value was less than 0.05. 
Shotgun reads were trimmed for quality and to remove sequence adapters using 
Trimmomatic v0.38 [124] with the following parameters: trimmomatic-0.38.jar PE -phred33 
ILLUMINACLIP: NexteraPE-PE.fa:2:30:10:1:TRUE LEADING:10 TRAILING:10 
SLIDINGWINDOW:4:15 MINLEN:60. Host reads were then removed using DeconSeq v0.4.3 




GCA_000001515.5, panTro5 for chimpanzee; Gorilla gorilla gorilla, GCA_900006655.1, 
gorGor5 for gorilla). To normalize for sequencing depth, all samples were rarefied to 4 million 
paired-end reads. For functional pathway analysis, we used HUMAnN2 v0.9.4 [35] to calculate 
relative abundance of annotated microbial gene pathways in the MetaCyc database [215]. Since 
HUMAnN2 does not take paired-reads into account, forward and reverse paired-end reads were 
combined. The resulting output was normalized to copies per million (CPM) 
(humann2_renorm_table) and samples were joined into a combined table (humann2_join_tables). 
Downstream statistical analysis was performed in R. Bray-Curtis distances and Adonis 
significance testing were computed using the vegan package [216]. All of the box and whisker 
plots represent the 1.5×interquartile ranges in the boxes, medians (50th percentiles) are indicated 
by the bars within the boxes, the whiskers below and above the box indicate the 10th and 90th 
percentiles, and the outliers beyond the whiskers are indicated with black circles if all data points 
are not shown. All statistics for boxplot analyses are based on Kruskal-Wallis tests and if 
significance is indicated two-tailed P-values were calculated using the Wilcoxon rank sum test. 
3.4.4 Functional metagenomics and analysis 
 
 Due to a limited amount of metagenomic DNA available from individual samples, we 
pooled samples within host groups to create 16 separate functional libraries (Supplementary Table 
3-1). Functional metagenomic libraries were prepared and created as previously described [12]. 
Briefly, small-insertion (~3-6 kb) expression libraries were created from 5 µg of pooled 
metagenomic DNA in vector pZE21 and transformed into E. coli MegaX DH10B electrocompetent 
cells. We screened libraries on Mueller-Hinton agar plates containing 12 natural and synthetic 




the growth of non-transformed MegaX cells. PCR was performed on pooled resistant colonies with 
vector-specific primers, barcoded, and sequenced.  
Sequenced reads were filtered, demultiplexed, and assembled into contigs with PARFuMS 
v1.1 [167]. We removed all contigs from selections where the number of contigs was more than 
ten times the number of colonies that grew on the selective agar. Contigs smaller than 500 bp were 
also removed from further analysis and ORFs were annotated using Resfams v1.2 [217]. We 
identified 887 contigs which resulted in 332 ORFs that could be classified with high confidence 
as ARGs related to the screened antibiotic class. Using ShortBRED v0.9.4 [36], we clustered 
identified ARG protein sequences from functional metagenomic selections and ARG protein 
sequences from the CARD database [188] with a cluster identity of 90% and used Uniref90 as a 
reference database for marker creation. We generated 3,092 unique markers for 907 ARG clusters. 
To measure the abundance of these markers, relative abundance tables normalized to RPKM were 
created using the shortbred_quantify.py script to identify ARG markers in the shotgun 
metagenomic reads from all our samples. 
3.4.5 Microbiome and resistome comparisons to published cohorts 
 
 For 16S external analysis, we downloaded public sequencing data of the V4 region of the 
16S rRNA gene from subsistence farmers in El Salvador [163], Hadza hunter-gatherers [170], 
Amerindians [144], and cohorts living in the USA [144], Malawi [144], a peri-urban shanty-town 
in Lima, Peru [163], and captive gorillas from zoos in the USA, France, and Switzerland [175]. 
Downloaded data was combined with sequencing reads from this study and all 16S DNA 
sequences were trimmed to 100 bp to match the length of the shortest downloaded sequences. 
Samples were rarefied to 9,800 single end reads and the same metagenomics analysis was 




 For shotgun analysis, we downloaded public shotgun sequencing data from subsistence 
farmers in El Salvador [163], Hadza hunter-gatherers [147], and cohorts living in the USA [146], 
Tunapuco, Peru [146], a peri-urban shanty-town in Lima, Peru [163], and wild gorillas from the 
Sangha region of the Republic of the Congo [140]. After removing all samples from individuals 
less than 3 years old we randomly selected up to 20 samples from each cohort. We checked for 
adapters using FastQC v0.11.7 [218]. The sequencing reads appeared to be of good quality and 
contained no adapters, so we removed host reads using DeconSeq and the human reference genome 
listed above. The public data contained several samples with less than four million reads, the cutoff 
used for analysis of Congo humans and wild and captive apes above, so samples were rarefied to 
three million reads and samples with less than three million reads were removed from analysis. 
DNA sequencing reads were trimmed to 100 bp to match the length of the shortest downloaded 
sequences. Some cohorts only had single-end reads so only forward reads were used from paired-
end data. Functional analysis was performed using HUMAnN2 as described above. Resistome 
analysis was performed using ShortBRED with the same parameters as above. 
3.4.6 Colistin resistance analysis 
 
 The PAP2 gene identified in the functional metagenomic selections was synthesized into 
the pZE21 vector by Synbio Technologies (Monmouth Junction, NJ). The plasmid was 
transformed into E. coli DH10B and MIC testing was performed using a Colistin ETEST strip 
(bioMérieux Inc) and confirmed in triplicate using ComASP Colistin Broth Microdilution 
Susceptibility Testing plates (Liofilchem). 





 16S rRNA and shotgun metagenomic Illumina sequencing data of human, chimpanzee, and 
gorilla samples is available from the Sequence Read Archive (SRA) under 
accession PRJNA539933. 16S rRNA data is de-multiplexed and trimmed. Shotgun metagenomic 





3.5 Supplemental Figures 
 
Figure 3-S1: Discriminating taxonomic changes in captive and wild apes. (A) Heatmap of 
Bray-Curtis distances between host cohorts. (B) Alpha diversity of humans, chimpanzees, and 
gorillas calculated using Shannon diversity (Kruskal-Wallis P = 8.9e-6; Wilcoxon rank sum test 
with Benjamini-Hochberg correction P  0.0076). (C) Boxplot of 16S sequencing depth (Kruskal-
Wallis P = 0.18) (D) Cladogram of discriminatory taxa identified in captive and wild chimpanzees 
(LEfSe LDA log score >4.5, P = 0.05). (E) Cladogram of discriminatory taxa identified in captive 





Figure 3-S2: Functional pathway analysis of host microbiota. (A) Heatmap of Bray-Curtis 
distances of functional pathways. (B) PCoA pot of Bray-Curtis distances of the relative abundance 
of functional pathways from HUMAnN2 results for chimpanzees and gorillas. (C) Discriminatory 
functional pathways identified in captive chimpanzees (CC), captive gorillas (CG), humans, wild 
chimpanzees (WC), and wild gorillas (WG) (LEfSe log score > 3.5, P = 0.05).  





Figure 3-S3: Functional metagenomic resistome analysis of humans chimpanzees and 
gorillas. (A) Heatmap showing functional metagenome growth results on selective media. Blue 
squares indicate that colonies were present and white squares indicate no growth was present. 
Functional libraries are named as described in Supplementary Table 1. (B) PCoA of Bray-Curtis 
distances of ARG abundance of chimpanzee and gorilla normalized with RPKM. (C) PCoA plot 
of Bray-Curtis distances of ARG diversity (presence/absence) of chimpanzee and gorilla 
resistomes. (D) Heatmap of Bray-Curtis distances of ARG abundance using Bray-Curtis distances 






Figure 3-S4: Alignments of ARG containing DNA fragments with high similarity across host 
cohorts from functional metagenomic selections. (A-H) The library from which the contig 






Figure 3-S5: Endogenous expression of colistin ARG is highly resistant to colistin. (A) MIC 
of colistin against empty vector (EV) control and the novel colistin resistance protein (CL H8). (B) 
Phylogenetic tree of the colistin resistance protein to the closest BLAST hits from the NCBI non-
redundant protein database accessed May 18, 2019. Percent identity and percent coverage are 






Figure 3-S6: Comparison of ape microbiomes to human microbiomes along a gradient of 
Westernization. (A) Heatmap of Bray-Curtis distances of 16S microbiome data normalized using 
relative abundance. (B) Shannon diversity of apes and humans along a gradient of Westernization 
(Kruskal-Wallis P = 1.5e-6; Wilcoxon rank sum test P  0.049). (C) Heatmap of Bray-Curtis 
distances of functional pathway abundance normalized using counts per million. (D) Heatmap of 
Bray-Curtis distances of ARG abundance normalized using RPKM. For this analysis one wild 
chimpanzee sample had no identified ARGs and was subsequently removed from distance analysis 




Table 3-S1: Pooling scheme for functional metagenomic library preparation. Metagenomic 
DNA was pooled to create 5 µg expression libraries. Extractions with low concentrations required 
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Conclusions and Future directions 
4.1 Lignocellulose degradation by R. opacus 
  
 In Chapter 2, we identified aromatic funneling enzymes and transporters present in R. 
opacus through a combination of RNA-seq and protein identity. Identification of these enzymes 
allows for the enhancement and possible introduction of these genes into other bacterial strains 
used for biofuel production. Identification of degradation enzymes across various microbial taxa 
increases the toolbox available for strain engineering that can then be introduced into wild type R. 
opacus strains in order to optimize biofuel production. This engineering can be further guided by 
metabolite profiling and metabolic flux analysis that was recently published [219]. 
Further, through adaptive evolution we found, surprisingly, that none of the mutations 
found in strains adapted on phenolic compounds were located in genes involved directly in 
degradation of phenolic compounds. The two genes found in the most strains, superoxide 
dismutase and cytochrome ubiquinol oxidase subunit I, are involved with redox reactions. 
Superoxide dismutase quenches radical oxygen species by converting them to either oxygen or 
hydrogen peroxide molecules, hydrogen peroxide can then be further degraded to oxygen and 
water [118]. Increased activity in this protein may help counteract the radical oxygen species that 
are created in aromatic xenobiotic toxicity.  However, we found the opposite to be true: the adapted 




indicating reduced activity in the mutated superoxide dismutase. We hypothesize that the increased 
amount of superoxide radicals allows for faster oxidation of the phenolic aromatics since  
degradation enzymes have to generate superoxide radicals to catabolize aromatic compounds [101, 
102]. In consort with this, mutations in the cytochrome ubiquinol oxidase subunit I may also 
increase the concentration of oxygen species within the cell, making them available for aromatic 
oxidation. Cytochrome ubiquinol oxidase is the last stage of the electron transport chain, and its 
main function is the final step where electrons are loaded onto oxygen species, reducing them to 
water [119]. Less efficient activity of this enzyme should thus result in increased oxygen species 
within the cell but with a cost: some energy is lost from decreased activity of the electron transport 
chain. However, we did not measure the activity of cytochrome ubiquinol oxidase directly, and it 
is possible that the mutations introduced into this enzyme enhanced the enzyme activity. Future 
work can be performed to determine if the introduced mutations increased or decreased enzyme 
activity. 
 This study’s limitations included the use of model lignin breakdown products instead of 
real-world lignin and the difficulty of making genetic alterations in R. opacus. The aromatic 
compounds used in this study are only a few of the large moiety of aromatics created during lignin 
depolymerization. Depolymerized lignin was not used in this study due to limited production 
capabilities and the tendency of depolymerized lignin mixtures to degrade over time. Although the 
use of simplified model compounds was not ideal, it provided consistent selective pressure for the 
adaptation experiments, and the resulting findings can be applied to engineer a strain for lignin 
depolymerization products. Also, at the time of this project, we did not have the tools necessary to 
make single nucleotide alterations in the R. opacus genome, so we were unable to determine the 




combinations of mutations are contributing the most to the increased aromatic tolerance 
phenotype. Further work is necessary to introduce these mutations into the WT background of R. 
opacus to determine the relative contribution of each of the SNPs that we found in adapted strains. 
However, characterization of all 255 distinct SNPs is impractical, so initial analysis could be 
simplified by targeting the SNPs that occurred across more than one adaptation experiment (see 
Fig. 2-3B). 
4.2 Antibiotic resistance in human and ape microbiomes 
 
 In Chapter 3, we found that antibiotic treatment and captivity is associated with an increase 
in antibiotic resistance gene (ARG) richness and abundance. The increased presence of ARGs in 
antibiotic-treated hosts supports the hypothesis that antibiotic usage selects for resistant bacteria. 
The abundance of resistance genes increases as resistant bacteria start to dominate the community 
and as ARGs are disseminated to otherwise susceptible strains through horizontal gene transfer 
(HGT). We found evidence that some ARGs are shared across host species, even when the hosts 
are geographically distant. These shared ARGs are found within similar genetic contexts, with 
some genes being colocalized next to mobile elements, indicating an increased propensity for 
HGT. These genes may have spread across host microbiomes through transfer from one bacterial 
strain to another. However, we can’t rule out the possibility that these individual ARGs may be 
found in a bacterial species that is shared across the microbiomes and thus inherited vertically 
rather than horizontally.  
 We identified several novel ARGs through our functional metagenomic selections. These 
genes included resistance to a number of antibiotics, including aminoglycosides and colistin, an 
antibiotic of last resort [198]. Discovery of novel ARGs provides the opportunity to characterize 




resistance genes, termed the tet destructases, from functional metagenomic selections provides a 
great example of the power of this method. These ARGs were initially discovered in environmental 
soil samples and have now been characterized [52, 193]. This initial characterization has led to the 
development of tet destructase inhibitors that rescue tetracycline antibiotics from these resistance 
genes [220]. Inhibition of tet destructase enzymes is increasingly relevant to human health 
outcomes because tet destructases have now been found in human pathogens [221, 222]. The 
discovery and characterization of tet destructases provides an ideal example for how ARG 
surveillance can lead to clinically relevant outcomes. However, The functionally identified novel 
resistance genes from this study and several other studies has mostly been ignored with little to no 
follow up studies on the novel ARGs identified [54, 151, 163, 223]. The colistin resistance gene 
identified in this study provides a good candidate for further characterization. Future research can 
be performed to characterize the mechanism of resistance and to determine if this gene can confer 
colistin resistance in human pathogens such as Acinetobacter baumannii. Further work can 
categorize these novel ARGs by finding all of the ARGs identified in these studies with similar 
antibiotic targets and mechanisms (e.g. the aminoglycoside methyltransferases or beta-lactamases) 
and creating phylogenetic trees to visualize the divergence of these genes from known ARGs 
within the categories. After distinct groupings are identified, representative genes can be assayed 
to confirm the resistance phenotype and further characterization can be performed on the genes 
most dissimilar to known resistance genes. This approach will lead to a better understanding of 
ARG diversity and may provide insight to guide ARG inhibition in the future. 
4.3 General Conclusion 
 
 In individual isolates equipped with xenobiotic degradation genes, xenobiotics selected for 




modifications may be harnessed to create an optimized strain through genetic engineering. In 
microbial communities with varying levels of xenobiotic tolerance genes, antibiotic selection 
pressure was associated with an increased abundance of tolerance genes within the community, 
highlighting the dangers of antibiotic overuse. Overall, knowledge of xenobiotic tolerance in 
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